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SUMMARY
Hereditary haemochromatosis (HH) is an autosomal recessive iron storage disease where
the accumulation of iron in parenchymal organs may lead to diabetes, heart failure, liver
cirrhosis, arthropathy, weakness and a variety of other ailments if preventive measures are
not taken. HH is often not considered as a cause of these conditions, particularly not in the
elderly where the background frequencies of type II diabetes, osteoarthritis and heart
failure are generally high. Heterozygosity for C282Y, the HFE-mutation causing HH in
approximately 80% of affected individuals worldwide, has been linked to a raised
incidence of malignancies of the colon and rectum, stomach and the haematological
system. One of the highest carrier-frequencies (116) in the world for this mutation has been
reported in the South-African Afrikaner population, resulting in C282Y-homozygosity in
approximately 1 in every 115 people in this group.
A sample of 197 elderly Afrikaner volunteers was recruited for genotype/phenotype
association studies. Their clinical presentation was denoted, biochemical iron-status
determined and HFE genotyping performed. Either an increase or decrease in survival, or
both, were proposed, depending on possible gender effects. HH has been positively
associated with various cancer types, but may also protect against iron-deficiency anaemia
which is by far the most frequent cause of anaemia in the older person.
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This study has led to the following findings:
1. The carrier frequency of mutation C282Y was found to be 1/8 in the elderly population
(similar in males and females), which is slightly lower than the 1/6 reported in younger
adults from the same population. Only one C282Y homozygote and two C282YIH63D
compound heterozygotes were detected, all of them female.
2. The prevalence of diabetes, heart disease, arthropathy or a combination of these
conditions did not differ significantly in C282Y heterozygotes and the mutation-
negative group.
3. Among 24 C282Y heterozygotes only one individual with rectal carcmoma was
detected compared with two cases with rectal- and seven with colonic malignancies in
153 mutation-negative individuals. The single female C282Y homozygote identified
suffered from both rectal and colon carcinoma and died approximately 6 months ago as
a consequence of her colon malignancy.
4. Serum ferritin appears to be a highly unreliable parameter of iron status, particularly in
the elderly where a variety of factors that may influence the levels are often present in
elderly individuals. This may be due to ageing alone or as a result of multiple co-
morbidities.
5. Serum ferritin levels were lower than expected in elderly subjects with mutation
C282Y and compound heterozygotes with both C282Y and H63D, which may be
related to a variable penetrance of the HFE gene mutations. It is possible that variation
in other genes exist that confer protection against iron-loading by gene-gene
interaction. The probability that environmental factors (e.g. a low iron diet) are more
important in this respect cannot be excluded, although this is considered less likely in
the light of the fact that the same trend was observed in all mutation-positive elderly
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individuals. It is therefore highly likely that C282Y -positive subjects with significant
iron loading have died before reaching their seventies, particularly since none of the
males included in this study were homozygous or compound heterozygous for the
mutations analysed.
In conclusion, possession of a mutant HFE gene does not appear to confer a survival
advantage in old age, neither does it seem that mutation carriers with significant iron-
loading are overlooked by the medical fraternity. Further investigations are warranted to
shed more light on the contributions of gene-gene and gene-environment interaction in the
clinical manifestation of Hll, and how these processes can be manipulated to prevent the
symptoms of this largely underdiagnosed disease.
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OPSOMMING
Oorerflike hemochromatose (OH) is 'n outosomaal resessiewe yster-oorladingssiekte waar
akkumulasie van yster in parenkimale organe kan lei tot suikersiekte, hartversaking, lewer
sirrose, artropatie, moegheid en 'n verskeidenheid van ander probleme indien
voorkomende maatreëls nie getref word nie. OH word gewoonlik nie oorweeg as
moontlike oorsaak vir hierdie toestande nie, veral nie in ouer mense nie waar die
agtergrond-frekwensie van tipe II diabetes, osteoartritis en hartversaking in elk geval hoog
is. Heterosigositeit vir die HFE mutasie C282Y, wat OH veroorsaak in ongeveer 80% van
geaffekteerde gevalle wêreldwyd, is geassosieer met 'n verhoogde voorkoms van kanker
van die kolon, rektum, maag en ook die hematologiese sisteem. Van die hoogste draer
frekwensies ter wêreld vir hierdie mutasie (1/6) is gevind in die Afrikaner populasie van
Suid-Afrika, wat daarop dui dat 1 uit elke 115 mense in die groep homosigoties vir die
C282Y mutasie kan wees.
Eenhonderd sewe-en-negentig bejaarde Afrikaner vrywilligers het aan die studie
deelgneem wat daarop gemik was om genotipe/fenotipe korrelasies uit te voer. Die kliniese
beeld van elke individu is gedokumenteer, die yster status biochemies bepaal en HFE
genotipering uitgevoer. Die cl priori veronderstelling was dat oorlewing sou toeneem of
afueem, of beide, afhangende van die geslag van die individu. Daar is voorheen 'n verband
gevind tussen OH en die ontwikkeling van bogenoemde maligniteite, maar aan die ander
kant kan dit moontlik ook beskerm teen anemie as gevolg van yster gebrek, wat juis die
mees algemene oorsaak van anemie in die ouer persoon is.
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Hierdie studie het tot die volgende bevindings gelei:
1. Die draer frekwensie van mutasie C282Y was 1/8 in die bejaardes (dieselfde in mans
en vrouens), wat effens laer is as die 1/6 wat gerappoteer is in jonger volwassenes.
Slegs een C282Y homosigoot en twee C282YIH63D saamgestelde heterosigote IS
opgespoor, en al drie was vroulik.
2. Die voorkoms van suikersiekte, hartsiekte, gewrigspyne of 'n kombinasie van hierdie
aandoenings het nie betekenisvol verskil tussen die C282Y heterosigote en die mutasie-
negatiewe groep nie.
3. Daar was slegs een persoon met rektum karsinoom in die groep van 24 bejaarde C282Y
heterosigote, terwyl daar twee gevalle met rektum kanker en sewe gevalle met kolon
kanker gevind is onder die 153 mutasie-negatiewe individue. Die enkele vroulike
C282Y homosigoot wat opgespoor is het beide rektum- en kolonkanker gehad en is
ongeveer 6 maande vóór voltooing van die tesis oorlede aan haar kolon karsinoom.
4. Dit wil voorkom asof serum ferritien veral in bejaardes 'n hoogs onbetroubare maatstaf
is vir yster status, aangesien dit deur 'n verskeidenheid faktore beïnvloed word wat
dikwels in bejaardes aanwesig is as gevolg van veroudering of veelvuldige ko-
morbiditeite.
5. Die serum ferritien vlakke was laer as verwag in sowel die bejaarde C282Y-
homosigoot as in die twee saamgestelde heterosigote met mutasies C282Y en H63D,
wat moonlik die gevolg is van die wisselende graad van penetrasie van HFE mutasies.
Dit is moontlik dat variasie in ander gene beskerming bied teen yster-oorlading deur
middel van geen-geen interaksie. Die moontlikheid dat omgewingsfaktore (soos 'n lae-
yster dieet) 'n belangrike rol speel in hierdie verband kan nie uitgesluit word nie,
hoewel dit minder waarskynlik lyk te wees in die lig van die feit dat dieselfde neiging
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waargeneem is in alle mutasie-positiewe bejaardes. Die kans is dus redelik groot dat
individue met die C282Y mutasie en betekenisvolle yster oorlading oorlede is voordat
hulle die sewentiger jare kon bereik, veralomdat geeneen van die mans wat ingesluit is
in die studie homosigoot of 'n saamgestelde heterosigoot was vir die mutasies wat
geanaliseer is nie.
Opsommend wil dit voorkom asof die teenwoordigheid van 'n mutante HFE geen nie 'n
beter oorlewingskans bied op ouer leeftyd nie, en dit blyk ook dat mutasie draers met
betekenisvolle ysteroorlading nie deur dokters misgekyk word nie. Verdere navorsing is
nodig om meer lig te werp op die bydrae van geen-geen- en geen-omgewing interaksie in
die kliniese manifestasie van OH, en ook hoe hierdie prosesse gemanipuleer kan word om
die simptome van hierdie onder -gediagnoseerde siekte te voorkom.
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Ca
Ca++
CNS
DMTI
Fe
Fer
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HFE
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INF-g
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LIST OF ABBREVIATIONS
Alzheimer's disease
carcmoma
calcium ion
central nervous system
divalent metal transporter 1
iron ron
ferritin
haemoglobin
hereditary haemochromatosis
human Fe gene
hydrogen peroxide
interferon-gamma
iron responsive element
iron regulatory protein
labile intracellular pool of iron
messenger ribonucleic acid
nitric oxide
non-transferrin-bound iron
natural resistance-associated macrophage protein
red blood cell
reticulo endothelial system
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SFer serum ferritin
Tf transferrin
TiR transferrin receptor
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1CHAPTERl
Introduction
Iron status in old age: An overview
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21.1 The role of iron in health and disease
The iron status of an individual is determined by a combination of nutritional,
environmental and genetic factors. Normal iron status ensures immediate availability of
iron for metabolic activity, including functioning of the immune system, while at the same
time impeding uptake by microorganisms and denying growth advantages to tumour cells.
How far one can go to either side of the "normal" situation without upsetting this balance is
probably the critical factor in understanding how changes in iron status can predispose to a
wide variety of disorders, including infectious, inflammatory, neurologic and neoplastic
disease. Iron is indispensable for life, mainly because of its role within oxygen-binding and
respiratory proteins, but may also lead to the production of free radicals and consequently
tissue damage (Bothwell et al. 1979). This may be particularly relevant in the elderly, since
many of the age-related diseases (e.g. atherosclerosis-induced disorders, malignancies) are
known to be at least partly due to chronic tissue damage related to formation of free
radicals.
Little is known regarding iron status in old age. Most of the research on iron status that has
been performed in the elderly has incorporated individuals up to 70 or 75 years of age (the
"young-old": NHANES-studies), but few studied included elderly subjects between 75-80
years of age (the "old-old"), and even less included subjects over 85 years of age (the
"very-old"). Most research into the basic mechanisms was performed on aged mice, rats,
pigs or dogs. Although this is probably the best that can be done at present, mechanisms in
these animal models are not always equal to those in the human body as species
differences exist in the extraction of iron from food, its absorption and excretion (Lynch et
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3al. 1982). More is known concerning haematological data, but flaws in study design have
rendered the data obtained in many of these studies unreliable (Miller 1939; Hobson and
Blackburn, 1953; Myers, 1968; Elwood et al. 1971; Smith and Whitelaw, 1971; Milne and
Williamson, 1972; Kelly and Munan, 1977; Kalchthaler and Rigor, 1980; Lipschitz et al.
1981; Zaino, 1981; Osterlind et al. 1984; Yip et al. 1984). There is still much controversy
whether parameters of iron status generally applied in the adult population can be used
reliably in the aged (Dybkaer et al. 1981). The current opinion is that for practical purposes
haematologie values in healthy elderly men and women are similar to those of young
adults (Zauber and Zauber, 1987).
It is therefore clear that "fragmentary knowledge" would be the best term to describe our
level of understanding of the processes involved in iron metabolism, particularly in old
age. Part of the problem is the lack of insight into the specific mechanisms that underlie
iron-absorption, iron-transport, iron-storage and the regulation of all these processes
locally in the intestine and between the different organs and systems that utilise iron. In the
next sections a summary of the known information will be presented.
1.2 The Iron Compartments
As most physiological processes change with the ageing of the body, either due to wear-
and-tear of tissues and organs or as result of depletion of essential building processes
necessary to replace lost or damaged structures, so do the elements that make up the iron
compartments. In the human body, iron exists in six compartments (Milman et al. 1986):
1) haemoglobin
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42) a storage compartment consisting of ferritin (present in virtually all cells of the body and
tissue fluids) and haemosiderin (in the reticulo-endothelial system (RES))
3) myoglobin
4) a labile intracellular pool (LIP) where iron is bound to cell membranes and intra-cellular
proteins for short periods of time before it is being incorporated into haem or iron-
containing proteins; metabolic redox-active forms of iron have also been found here
5) a tissue-compartment with the iron located in a variety of enzymes
6) the transport compartment, consisting of the transport protein transferrin (Tt). Iron is
being turned over at least ten times a day and transferrin is the final common pathway for
interchange between all compartments.
Haemoglobin
In adulthood the haemoglobin (Hb) concentration is significantly higher in males than in
females and this difference continues to exist in old age. Aged males show a continuous
decline in haemoglobin-concentration (figure1), with the difference best seen when the Hb
of the age-group of 60-79 years old is compared with the Hb of those 80-93 years old, but
this difference is not statistically significant (Milman et al. 1986). This decline might be
related to the physiological decrease in testosterone production well known to occur in
males over 80 years of age, as aged females do not show this age-related lowering (figure
1). The other two hormones that have an influence on erythropoiesis (thyroid hormone and
erythropoietin) do not significantly decrease in healthy elderly individuals (Denham and
Himsworth, 1984; Powers et al. 1989), although the bone-marrow response to these
hormones might change with ageing (Lipschitz et al. 1984), as does its reserve capacity.
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Figure 1. Age-related changes in haemoglobin (Yip et al. 1984, Milman et al. 1986,
Kruger, 1987).
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6Ferritin
Ferritin consists of a hollow protein shell, composed of 24 heavy and light chains forming
four-helix bundles that each form a channel, and a mineral core in the middle as a Fe-
storage cavity (Lawson et al. 1991). The hollow shell is called apoferritin and ferritin is
formed when ferri-hydrite is deposited inside in the mineral core. It is produced
intracellularly in virtually all cells of the body. The major function of ferritin is the
sequestration of excess intra- and extra-cellular iron and to store this highly reactive ion in
a biochemically inert form in order to prevent development of oxygen radicals. The
intracellular ferritin is in direct equilibrium with the serum ferritin concentration, which is
the small fraction of the body ferritin that circulates in the blood. Approximately 30% of
total body iron is bound to ferritin and in healthy adults the serum ferritin is in direct
equilibrium with the level of saturation of all the other iron-stores in the body. Men have
higher ferritin levels than women and again this difference continues into old age (Milman
et al. 1986). Although elderly men have slightly higher levels than young men this does not
reach statistical significance, in contrast to elderly women who start accumulating iron
after the menopause (figure 2, Milman et al. 1986). Other measures of iron storage, that is
hepatic non-haem iron (Charlton et al. 1970; Sturgeon and Shoden, 1971) and bone-
marrow iron (Benzie, 1963), have been found to increase with age, particularly in females.
However, a variety of factors have been identified that raise the serum ferritin
concentration without any relationship to iron status per se, as ferritin is an acute phase
protein. These include any underlying acute or chronic inflammatory disorder which
releases ferritin from affected tissues (Marcus and Freedman, 1985), exercise (Malczewska
et al. 2000), alcohol use (Lipschitz et al. 1974), hepatic and ovarian malignancies (Lundin
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7disorders, which may render serum ferritin an unreliable measure of body iron status
in this age group.
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Figure 2. Age-related changes in serum ferritin (sf) (Yip et al. 1984, Milman et al.
1986)
Stellenbosch University http://scholar.sun.ac.za
8Haemosiderin
Haemosiderin is an insoluble protein-iron complex mainly found in the cells of the
monocyte-macrophage system, although with bleeding it does accumulate locally in the
tissues. It is probably derived from ferritin molecules by partial lysosomal digestion. The
effects of ageing on this system and on haemosiderin are basically unknown.
Myoglobin
Myoglobin forms the oxygen-reserve of the muscle fiber. With ageing the number of
muscle cells decreases, as does the contractile power of the surviving cells. Although the
effect of old age on myoglobin or its iron-component has not been studied, it will most
likely not be of much significance to the iron status of the individual. In the normal adult
male it makes up only 3.5% of the total body iron, compared to 67% in haemoglobin and
27% in the storage-compartment (Marcus and Freedman, 1985).
Transferrin
Although the transport protein transferrin (Tt) contains only 0.08% of total body iron, it is
the common pathway for communication between all the other compartments and it is
readily measurable. In cases with normal liver function, if individuals are not using
oestrogens (which raise serum Tt) and if there is no nephrotic syndrome or a chronic
illness with a low plasma iron concentration (which both lower serum Tt) (Zilva et al.
1987), no statistically significant change with age or between the sexes has been found
(figure 3, Milman et al. 1986, Franzini et al. 2000). The same holds true for the serum iron
concentration (Franzini et al. 2000)
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1984, Milman et al. 1986)
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No data could be obtained on any age-related changes in the labile pool of iron or the
tissue iron-compartment where the iron is part of proteins and enzymes.
1.3 Iron Metabolism
Iron intake
Haemoglobin and myoglobin in meat, leafy green vegetables, iron-fortified cereals and
egg-yolk contain absorbable iron. Haem-iron can be more readily absorbed than inorganic
iron, but elderly people are universally known to eat less meat than younger adults. Iron
intake is in direct proportion to the caloric intake of the individual. With ageing both
caloric needs and iron-requirements decrease as processes of growth have stopped and
much less energy is used in daily life. In spite of the relatively low meat consumption
mentioned above and the decreased bio-availability mentioned below, the elderly usually
seem to have an adequate iron intake (Lynch et al. 1982; Bunker et al. 1984). As very little
iron is lost from the body an older person needs a daily intake of about 1 mg of iron
(Marcus and Friedman, 1985).
Bio-availability
In old age bio-availability of iron is decreased due to a number of factors:
1. As mentioned above, the amount of iron that is available from haem iron declines
parallel to meat consumption. When haem iron is taken with food, its absorption is not
dependent on the food composition in the same way as non-haem iron, but it has been
found that pure haem iron is relatively poorly absorbed. This is probably due to the
formation of non-absorbable haem-polymers (Conrad et al. 1966) and the fact that
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uptake is markedly increased when either meat or soy-protein is present (Lynch et al.
1985). These other protein-products may preserve haem in the monomeric state. It has
repeatedly been found that the elderly consume less meat than adults, which is amongst
others due to a decreased ability to chew meat properly and the age-related
physiological decrease in saliva production. This will decrease the bio-availability of
iron.
2. In the diet of many elderly people most iron is obtained from green vegetables and
cereals; these sources contain a variety of iron-chelators (oxalates, fiber, phytates and
phosphates, and other inhibitory ligands) that decrease the bio-availability and
absorption of non-haem iron.
3. Iron cannot be absorbed in the 3+ form, only as a ferric ion (2+). To transform iron
from 3+ to 2+ a reducing agent is needed, and the acid secreted in the stomach fulfills
this role in man. In old age this acid production declines significantly (Jacobs and
Owen, 1969), again lowering bio-availability.
Absorption
Iron absorption is highest in the proximal part of the duodenum but can take place
anywhere in the small intestine. Haem iron is absorbed via a pathway different from non-
haem iron, and has been shown to bind to a specific haem receptor (Grasbeck et al.
1979,1982). From here it rapidly enters the intestinal epithelial cell in microendocytic
vesicles, where it is split by haem-oxydase into free iron and a tetrapyrrole. This splitting
process seems to be the rate-limiting step in haem iron absorption (Wheby and Spyker,
1981). Haem in itself seems to promote the absorption of inorganic iron (Lynch et al. 1982;
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Turnlund et al. 1981), although large doses of either iron have been seen to inhibit the
uptake of the other (Hallberg et al. 1979). When the amount of iron in the food is
progressively increased, a linear increase in the amount of absorbed iron is found as the
percentage of iron that is absorbed stays constant (Hallberg et al. 1979; Bezwoda et al.
1983). The mechanism of these processes is unknown, but herein lies the inherent risk for
iron overload when the iron content of the food is above physiological levels. Added to this
is the fact that inhibition of absorption of haem iron is less pronounced at higher iron-
storage levels than the inhibition of non-haem iron (Lynch et al. 1989). Iron overload will
therefore more readily occur in societies with a high meat intake, and the aged are less
likely to load iron via this pathway. After cleavage the haem iron enters the same
intracellular pool as the non-haem iron and is transferred across the basal surface of the
mucosal cell to the portal circulation.
With ageing a lowered absorption has been documented (Marcus and Freedman, 1985;
Lynch et al. 1982; Bunker et al. 1984). Some speculation exists about the possible
mechanisms:
1. Wear-and-tear of the intestinal mucosa with advancing years leads to a decline in the
number of villi and villous as well as mucosal atrophy, resulting in lower con-
centrations of enzymes and a decrease in the available absorptive surface (Knook and
Goedhard, 1983).
2. As iron losses are negligible in older persons under normal circumstances, absorption
could diminish due to saturation of stores. The intestinal mucosa regulates iron-uptake
according to the saturation of the iron-storage compartment via a negative feedback-
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loop, and it has repeatedly been found that iron stores increase with age (Benzie, 1963;
Sturdeon and Shoden, 1971; Lynch et al. 1982; Lipschitz et al. 1984) thus lowering
absorption. How the message is received by the mucosal cells is not known; the
mechanism that leads to increased uptake when there is a surplus of iron in the
intestinal lumen available in spite of saturated iron stores is also unclear. There appears
to be controversy about the change in ferrous iron absorption with age, since this might
not change at all (Marx, 1979).
Excretion
Iron is excreted via stool and urine and can be lost with sweating. Excretion does not
appear to change with ageing (Lynch, 1982; Bunker et al. 1984; Marcus and Freedman
1985; Milman et al. 1986), but it should be noted that measuring excretion is extremely
difficult.
1.4 Regulation of iron metabolism
In the body there are Fe-receptor cells, such as RBC-precursor cells, duplicating and
growing cells and hepatocytes, as well as Fe-donor cells (e.g. macrophages, mucosal cells
of the duodenum) and also the hepatocytes. In addition, hepatocytes are able to scavenge
all forms of non-transferrin-bound iron (NTBI) from plasma and deliver Fe back to the
plasma in a form that is easily bound to apoferritin.
When iron is absorbed from food, it is probably transported by the divalent metal
transporter (DMT1), also known as the natural resistance-associated macrophage protein-2
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(NRAMP2). This transmembrane H+-coupled transporter of NTBI is localised in the
enterocytes at the apical and lateral aspects of duodenal villi (Wood and Han, 1998;
Trinder et al. 2000). Northern blot analysis indicated that mRNA transcripts are expressed
at low levels in normal tissue (Vidal et al. 1995). In iron-overload conditions such as HH,
DMT1 is found in high concentrations on the plasma membrane of hepatocytes (Trinder et
al. 2000) whilst m-RNA concentration may be increased 10-100 times in duodenal villus
enterocytes (Han et al. 1999), reflecting the high uptake of NTBI in these states. How the
iron is handled intracellularly in the labile intracellular pool of iron (LIP) is not known
(Atkinson and Barton, 1999), but as the LIP contains redox-active iron that may cause
oxidative stress, most of it should be sequestrated by molecules such as ferritin to attenuate
this oxidative stress (Ponka, 1999). What is known, however, is that intracellular Fe-
homeostasis is influenced by a regulatory system, where two forms of iron regulatory
protein (IRP) are found in mammalian cells (Ponka, 1999): IRP1, a cytosolic protein
homologous to mitochondrial aconitase and IRP2, also found in the cytosol. These IRP's
bind to iron responsive elements (IRE's) on mRNA for proteins that are involved in Fe-
uptake, storage and transport, of which the ferritin-mRNA translation and the post-
transcriptional regulation of the TtR-mRNA are studied best (Hentze and Kuhn, 1996;
Ponka, 1999). If intracellular Fe-concentration is low, IRP1 will bind on IRE's in TtR-
mRNA to stabilise it, and to IRE's on Fe-mRNA to inhibit its translocation. IRP1 is
regulated by Fe-concentration, downregulated by nitric oxide (NO) and upregulated by
INF-y; IRP2 is upregulated by NO+ and downregulated by INF-y (Hentze and Kuhn,
1996). IRP1 has been found to combine reversibly with an iron-sulphur-complex,
containing 4 Fe and 4 S atoms, which is called the iron-sulphur-switch. It is a prosthetic
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group, indispensable for Fe-containing enzymes in the cell and it plays probably an
important role in the binding ofIRPl to IRE's (Hentze and Kuhn, 1996). Absence of some
of these cluster-proteins has been found in Friedreich's Ataxia and certain mitochondrial
myopathies, and it is postulated that the cells that lack these clusters are targets of
oxidative destruction in these diseases (Gerlach et al. 1994). The binding of IRPI to the
clusters is influenced by Fe-levels and by hydrogen peroxide: a mediator of oxidative
stress (Hentze and Kuhn, 1996). Furthermore, some animals have been found to lack IRP2
and they develop progressive neurodegenerative disease due to Fe-accumulation in certain
cells in their central nervous system (CNS) (Gerlach et al. 1994).
At the basal membrane of crypt cells in the proximal small intestine, the transferrin-
receptor (TfR) is found, which is known to bind transferrin (Tt) extracellularly. When Tf
binds to TfR, a signal-cascade is activated, mediated by PB-kinase, activating RAC-
channels (Receptor Activated Calcium-channels) so that Ca++ enters the cell. Raised
intracellular Ca++ promotes secretion of Tf and intracellular Fe into the interstitial space,
where the Fe is to be bound to Tf to be transported into the portal circulation (Ponka,
1999). Some iron has also been seen to leave the cells vesicle-bound via exocytosis
(possibly ferrous-iron, which is stored in the cell in ferrochelatin, not in ferritin (Wood and
Han, 1998). If the TfR binds Fe-loaded-transferrin from serum, the transferrin is
internalised, sent to the endosomes where Fe is released and the Tf returns to the basal
membrane as apotransferrin to be secreted again (Wood and Han, 1998; Ponka, 1999).
Another protein that may influence the efllux of iron from intestinal cells is hephaestin, a
glycosylated integral membrane protein, present in duodenal cells, probably at the basal
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membrane. It seems to be the intracellular Fe-concentration in the cells of the intestinal
mucosa however, that determines apical iron-uptake.
At the TiR-site, the normal HFE-protein binds non-covalently to the receptor, suggesting a
role in the uptake of Tf-bound Fe by these cells. The C282Y-mutation, shown to cause RH
(Feder et al. 1996) in the majority of affected patients worldwide, disrupts a critical
disulfide bond in the a3 extracellular loop of the protein (Parkkila et al. 1997), which is
required for the binding of the HFE protein to the TiR. At the level of the intestinal cell,
the abnormal HFE protein acts as a competitive inhibitor of Tf, thus decreasing the affinity
of TiR for Tf (Han et al. 1999), while the efflux of iron from the mucosal cell remains
identical as do the receptor-distribution and receptor-intemalisation. This will lead to an
abnormally low intracellular iron concentration and these cells have been found to behave
as Fe-deficient, with a resulting up-regulation of DMTl. In monocytes and macrophages,
the mutated HFE-protein cannot be presented at the cells' surface as it cannot properly
interact with B2-rnicroglobulin, necessary for surface presentation, and this seems to lead
to lack of retention of Tf-bound Fe by these cells (Ponka and Lok, 1999). Regarding the
liver in Fe-overload states, the TiR on the hepatocytes is markedly down-regulated but iron
is taken up from diferric-saturated transferrin and from NTBI sources (Bonkovsky, 1991).
Ceruloplasmin supposedly also plays a role in the efflux of Fe from liver cells. This
mechanism, or that whereby haptoglobin (a Hb-binding plasma protein) may assist in
hepatic uptake ofHb (Bonkovsky, 1991) has not yet been elucidated.
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Cells can also accumulate iron via NTBI (Wood and Han, 1998), although ferric-iron
needs to be reduced to ferrous-iron before any transport can take place. NTBI is supposed
to arise when there is such an excess of Fe available that the Tf-capacity is exceeded; the
NTBI then is deposited in parenchymal cells leading to Fe-toxicity via hydrogen peroxide-
mediated damage to membranes inside the cell. There exist a variety of other Fe-
transporting proteins such as lactoferrin and the novel melanotransferrin (markedly raised
in AD sufferers), which has a high level of sequence homology to both Tf and lactoferrin.
In conclusion, a tremendous improvement in our knowledge regarding the mechanisms of
iron uptake, cell-trafficking, transport and storage would be required to understand the
processes involved in the handling of this important ion in the human body.
1.5 Determination of iron status
Even though there are a variety of iron-related tests with well-defined reference ranges for
age and sex, the fact that each test reflects a different aspect of iron metabolism means that
there is no single test that can define iron status or diagnose iron deficiency with a high
degree of certainty. Currently, iron deficiency is based on two or more abnormal tests out
of three tests utilised. In some cases the term "impaired iron status" is preferred, because
the combination of abnormal tests such as low transferrin saturation and elevated
protoporphyrin can be the result of metabolic disturbances related to inflammation rather
than nutritional iron deficiency. Measurement of the serum iron concentration alone
provides little useful clinical information because of the considerable variation from hour
to hour and day to day in normal individuals. Low serum ferritin is specific for iron
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deficiency as there are no conditions that cause falsely low serum ferritin values. A raised
serum ferritin is probably a highly inaccurate parameter of iron status, particularly in the
elderly, due to the many co-morbidities that increase the ferritin level. Serum transferrin
receptors are detectable in the circulation and appear to reflect the level of bone marrow
synthesis; this test may be useful in diagnosing iron deficiency when the individual has not
yet developed anaemia, but the determination is assay-dependent and further evaluation of
its usefulness is needed (Chua et al. 1999). These aspects emphasise the importance of
molecular studies aimed at the development of a comprehensive DNA-based assay for
determination of the genetic elements that influence iron-status and consequently the risk-
assessment of iron-overload and -deficiency conditions.
1.6 Iron status in old age
The iron status of older persons has fascinated clinicians for almost a century. Anaemia
due to iron deficiency - by far the commonest cause of a low haemoglobin in old age - is
often the presenting symptom of some major underlying disease. Moreover, a clinical
diagnosis is often difficult to make as many elderly only present when their anaemia is
already quite severe and symptoms have been wrongly accepted as one of the inevitable
evils of getting old. Part of the late presentation can also be explained by adjustments in
the oxygen-dissociation curve in anaemia, which causes the 2.3-diphospho-glycerate inside
the red cells to increase and thus the oxygen-dissociation curve to shift to the right. The
result is an increase in oxygen dissociation at a given oxygen pressure in tissue- capillaries,
which retards the development of oxygen-deficit in tissues and thus delays the appearance
of symptoms. On the other hand, in the aged anaemia can present in a much more life-
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threatening way than in adulthood, e.g. when it precipitates overt heart failure with lung
edema or causes delirium in an individual suffering from cognitive decline. During the last
two decades of the previous millennium, interest in the iron status of the elderly has risen
as a result of the discovery that hereditary haemochromatosis (Hlf) can present for the first
time in individuals over 65 years of age, and that elderly individuals who are homozygous
for the most common disease-causing mutation (C282Y) (Feder et al. 1996) do not
necessarily have any signs or symptoms of the disease or express their mutation as iron
overload (Willis et al. 1999). These findings have led researchers to question the lack of
recognition of the disorder by clinicians, the reliability of the tests used in the laboratory to
determine iron status and the necessity of population screening for disease-causing
mutations. Some of these questions will be dealt with in this thesis.
1.7 Iron overload in the elderly
Iron bio-availability and absorption are decreased in older individuals for various reasons,
whereas the stores in liver and bone-marrow are increased. Also, in the elderly iron uptake
increases with an increase in supply via food intake, in spite of saturated stores, so that a
propensity for iron-overload exists in aged individuals. The mechanisms underlying this
phenomenon are unknown.
Role of genetic factors
Hereditary haemochromatosis (HH) is a common, treatable genetic disease caused by
abnormal metabolism of iron. Excess iron is stored in organs and tissues where it causes
injuries that may result in a variety of disorders including heart disease, diabetes, arthritis,
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cancer, cirrhosis, impotence and sterility. Advancing age is significantly associated with
arthritis, cardiac disease and diabetes in patients with HH. Many of the "non-specific" HH
symptoms such as fatigue and arthritis are common in the ageing general population
without HH, and this may contribute to a lack of recognition of the disease in the elderly.
HH is transmitted as an autosomal recessive disease, wherein affected individuals inherit
two copies of the defective gene. The estimated carrier frequency of HH is between 1 in 8
and 1 in lOin most populations of European descent, resulting in a double dose of the gene
in about 1/300 individuals. Previous studies have shown that heterozygosity for HH is
associated with an increased risk of colorectal neoplasia, diabetes, haematological
malignancies and gastric cancer. Molecular-genetic research has resulted in the
identification of a common gene mutation (C282Y) associated with HH in more than 80%
of affected patients world-wide (Feder et al. 1996). Studies performed in the South African
population have shown that mutation C282Y also occurs at a high frequency (-80%) in
affected cases (de Villiers et al. 1999a). The carrier frequency of mutation C282Y was
found to be 1 in 6 among South Africans of European descent, implying that
approximately 1 in 115 individuals may be homozygous for this mutation. Identification of
healthy blood donors with the disease genotype has highlighted the need for further
genotype/phenotype correlation studies in South Africa, since probably only a small
number of individuals homozygous for the potentially lethal C282Y mutation are
presenting clinically. Underdiagnosis of HH can partly be ascribed to the non-specific
nature of the presenting features and the wide variety of disorders associated with this
disease.
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Gene-gene interaction
Little is currently known about the genetic factors that may influence iron stores in
humans. Extensive analysis of a large community sample of adult male and female twins
recruited from the Australian Twin Registry (Whitfield et al. 2000) has indicated highly
significanteffects of other as-yet-unidentifiedgenes on iron stores, in addition to the HFE
genotype (Figure 4). The remaining differences between monozygotic and dizygotic
correlations, after allowingfor HFE effects, showed that other genes account for ~45% of
the phenotypic variation in serum ferritin and for 30% of the variation in transferrin
saturation. Elucidation of the influence of genes affecting iron stores may provide a route
to understanding genetic differences in susceptibilityto a range of common diseases, since
heterozygosity for HH or mutation C282Y in the HFE gene has been implicated as a
causative/modifier locus or potential genetic marker for disease susceptibility/progression
in various conditions. These include cancer (Nelson et al. 1995), chronic liver disease
(George et al. 1998, 1999), porphyria (Roberts et al. 1997; de Villiers et al. 1999b),
inherited anaemias (Yaouanq et al. 1997), cystic fibrosis (Rohlfs et al. 1998), diabetes
(Kwan et al. 1998), cardiovascular disease (Tuomainen et al. 1999; Roest et al. 1999),
Alzheimer disease (Moalem et al. 2000), and possibly also HIV/AIDS progression
(Nielsen et al. 1999). Even in conditions where iron may not have a primary action, its
potential secondary role cannot be negated. HH therefore is an important paradigm for
medical genetics because it offers an opportunity to explore the complexity of gene-gene
and gene-environment interactions. Identification of elderly subjects with genotypes
compatible with HH would provide a valuable source of material to identify genes that
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phenotypic expression of HH, or may underlie a tendency to iron deficiency in the
general population.
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Figure 4. Proportion of variance ascribed to HFE gene variation, the additive effects
of other genes and the nonshared environmental effects in men and women. Total
variance in women has been standardised to 100 for each variable (adapted from
Whitfield et al. 2000).
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CHAPTER2
Objectives of the study
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Heterozygosity for the common autosomal recessive disease, hereditary haemochromatosis
(HH), is associated with an increased risk of colorectal neoplasia, haematological
malignancy and gastric cancer in the general population. The high proportion of patients
with HH who are homozygous for mutation C282Y provides us with a potentially powerful
tool for population screening. Unlike serum iron and ferritin levels, which have been used
previously for screening, the genotype is not affected by factors such as liver disease and
inflammation that can modify the levels of serum iron and ferritin both in
haemochromatosis and normal subjects. As in the case of other genetic diseases, one would
predict that the phenotype of C282Y homozygotes would vary markedly. Some would
probably never develop clinical disease. Yet, the treatment of haemochromatosis by
phlebotomy is so simple and effective that it would appear prudent to consider a
therapeutic phlebotomy program in individuals shown to have the homozygous genotype,
and/or to monitor their iron and ferritin levels. When the disease-causing mutation IS
identified in a family, all relatives can be screened and diagnosed with great accuracy.
We hypothesise that genetic variation in the lIFE gene may influence serum iron levels in
the elderly and that mutation C282Y, and/or other mutations(s) in the lIFE gene, may
affect life expectancy adversely due to increased cancer risk. The specific objectives of the
study were as follows:
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1. Determine the frequency of the BH mutation C282Y in the elderly for comparison
with the frequency found in young adults from the same population group, in order
to determine whether this founder-type mutation affects life expectancy adversely.
In a study of adults of the Afrikaner population-group a relatively high carrier frequency
for C282Y (1/6) has been found compared with other populations of Northern European
descent (1/8 to 1/10). As males with lll-I usually become symptomatic in their early fifties
and then are either diagnosed and treated, or die as a consequence of organ damage, we
were interested to know whether any undiagnosed C282Y homozygotes would survive
beyond the age of 70 years.
2. Compare the clinical features of elderly subjects with an BB genotype with those in
younger adults.
The clinical picture of Hli consists of a constellation of one or more non-specific disorders
affecting different organs (e.g. type II diabetes mellitus, heart failure, arthritis), which have
a high background frequency in the aged population of Northern European descent. Since
both ischaemie heart disease and arthritis are highly prevalent in the general Afrikaner
population many cases could potentially be missed by unwary physicians. From a
preventive perspective it could be highly cost-effective to increase general awareness if the
frequency oflll-l proves to be as high in the elderly as in their younger counterparts.
3. Perform genotype/phenotype correlation studies to assess whether the C282Y
mutation is associated with increased iron levels and/or cancer risk in the elderly.
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In previous studies associations have been reported between possession of one or two
C282Y mutations and a raised frequency of colorectal, gastric and haematological
malignancies. Most of these study groups have not been randomly selected (e.g. hospital
patients, clinic-attenders, diabetics) and selection-bias could have influenced the results.
The background frequency for colorectal neoplasms is especially high in the elderly and
possible early detection or even prevention by screening for Hlf might be worthwhile in
this age group.
4. Identify elderly subjects who are homozygous or compound heterozygotes for
mutations in the HFE gene for future gene-gene interaction studies, aimed at the
possible identification of modifier loci that may cause iron deficiency in the general
population.
Survival of individuals with the Hlf genotype is dependent on the degree of expression of
the relevant mutation(s). It has become clear that some C282Y homozygotes have no iron-
loading at all, and therefore the frequency of this genotype in the elderly could be an
indication of the frequency of homo- and heterozygote "non-loaders", based on the
assumption that iron-loaders would not survive into old age without being diagnosed. In
these individuals, modifier loci might be identified that prevent iron loading via gene-gene
interaction.
The project could lead to a better definition of clinical criteria for diagnosis of Hlf and
serve to determine the incidence of clinical! biochemical misdiagnosis of this common iron
overload disease.
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CHAPTER3
Results and Discussion
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ABSTRACT
The frequency of the hereditary haemochromatosis (IllI) mutation C282Y has been
determined in 197 elderly individuals, in order to determine whether this founder-type
mutation affects life expectancy adversely in the South African Afrikaner population of
European descent. The carrier frequency of mutation C282Y was approximately 1/8, which
is slightly lower than the 1/6 previously found in younger adults from the same population.
Subsequent screening of 24 C282Y heterozygotes for mutation H63D (with a relatively
mild phenotypic effect), led to the identification of two compound heterozygotes for these
mutations. The single C282Y homozygote reported a strong family history of cancer and
died of colorectal carcinoma approximately six months prior to completion of the
investigation. The serum ferritin concentrations of the elderly subjects with HH genotypes
and the C282Y heterozygotes were lower than expected, which raises the possibility that
mutation-positive cases with high levels had died at an earlier age due to adverse effects of
iron surplus. This was substantiated by the finding that all the individuals with a HH
genotype were females, suggesting a negative selection against males. Elderly subjects
with the HH genotype in combination with normal iron status can be expected to harbour
modifier genes that may lower serum iron levels with concurrent protection against organ
damage. This observation warrants further investigation into the role of gene-gene and
gene-environment interaction in clinical expression ofHH.
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INTRODUCTION
Hereditary haemochromatosis (RH) is an autosomal recessive disease characterised by iron
overload, which may damage parenchymal organs such as the liver, pancreas and heart,
leading to organ failure. Patients with this condition may also present with arthritis,
hypogonadism, pigmentation of the skin, and possibly also neurologic abnormalities
(Nielsen et al. 1995). Under-diagnosis of RH can partly be ascribed to the non-specific
nature of the presenting features and the variety of disorders associated with this disease.
Diagnosis is usually confirmed by measurement of serum transferrin saturation and ferritin
levels, but both parameters are influenced by external factors thus decreasing their validity.
Treatment of RH entails venesection or iron-chelation therapy. Although normalisation of
body iron content may halt disease progression, normal life expectancy would only be
possible through early detection prior to the onset of symptoms and regular blood donation.
Recent cloning of the HFE gene underlying RH now enables accurate disease diagnosis
(Feder et al. 1996). Screening for disease-related mutations, including mutations H63D and
C282Y shown to be responsible for the disease in more than 80% of cases worldwide, is
particularly useful in pre-clinical testing. The carrier frequency of mutation C282Y was
found to be 1/6 in the South African Afrikaner population (de Villiers et al. 1999a),
implying that approximately 11115 Afrikaners are homozygous for this mutation. This
finding emphasised the need for genotype/phenotype correlation studies in South Africa,
since not all individuals homozygous for the potentially lethal C282Y mutation are
clinically recognisable (Milani and Kotze 1999).
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Recently, Willis et al. (1999) reported the detection of several C282Y homozygotes in an
elderly male population (4 out of 600 male volunteers). Lack of recognition of Hlf in the
elderly may be due to the fact that many of the conditions (e.g. diabetes) and non-specific
features such as fatigue and arthritis that are associated with Hfl, are also common in the
general aged population without Hl-l. In this study the frequency of mutation C282Y was
determined in the elderly and compared with that in young adults, in order to assess
whether this mutation affects life expectancy and quality of life adversely in the South-
African Afrikaner population. Those individuals found to be heterozygous for mutation
C282Y were subsequently screened for mutation H63D, in order to determine whether
these mutations are associated with an increased risk of malignancy in the elderly. An
association with malignancies of the stomach, colon, rectum and the haematological
system has previously been reported in Hlf carriers (Nelson et al. 1995).
METHODS
Study population
The study population consisted of a sample of 197 volunteers (67 males, 130 females) over
70 years of age, from the Afrikaner community of South Africa. All the participants were
Afrikaans-speaking with their ancestors having been in South Africa for at least three
generations. The Afrikaner gene pool consists of 34.8% Dutch, 33.7% German, 13.2%
French, 5.2% British and 13.1% other nationalities (Botha and Beighton 1983).
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The study included South African participants from all parts of the country and various
social and professional backgrounds. They either stayed alone or with their children, or
lived in retirement- or nursing homes. Approximately one-third were healthy elderly living
independently, one-third nursing-home residents with all sorts of complaints but not ill as
such, and the remaining third consisted of hospitalised elderly with a variety of disorders
not directly indicative of possible iron overload (e.g. hip fractures, benign prostate
hypertrophy, type II diabetes, strokes, gynaecological problems, myocardial infarctions /
angina, psychiatric disorders, peripheral vascular disease, etc.). Of the 201 elderly who
were approached, 197 were readily available to take part in this study. All have been
recruited, examined and had their specimens collected by the same physician, which
largely excludes inter-rater variability. The four subjects who did not want to participate in
the study suffered from hip-fractures (two subjects), ischaemie heart disease and a mild
stroke. Since these cases comprise less than 2% of the study population no efforts were
made to perform follow-up studies. Informed consent was obtained after the possible
consequences of a positive test had been explained. A sample of 151 volunteers, including
49 medical students « 30 years of age) and 102 subjects «60 years of age) recruited from
the Afrikaner population, served as a control group.
Biochemical and DNA analysis
After completion of a questionnaire designed for the study and general physical
examination, blood was collected for biochemical iron profile determination and genetic
testing. The blood samples of only 178 of the 197 aged volunteers included in the study
were suitable for biochemical analysis due to haemolysis of some specimens. Serum iron
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was measured with a Beckman CX7 autoanalyser and transferrin with a Beckman Array
Nephelometer. Transferrin saturation was subsequently calculated. Genomic DNA was
extracted using a standard salting-out method (Miller et al. 1988), and amplified by the
polymerase chain reaction (PCR) as previously described (de Villiers et al. 1999).
Restriction enzyme analysis was performed to screen for mutations C282Y (RsaI) and
H63D (Mbol) (Feder et al. 1996; Roberts et al. 1997). All the samples were screened for
mutation C282Y, while only those found to carry this mutation were screened for mutation
H63D. Possible mistyping of C282Y homozygosity was excluded by MseI restriction
enzyme analysis as previously described (de Villiers and Kotze 1999).
Statistical analysis
Allele frequencies were determined by allele counting. Testing for significance of
heterogeneity in mutation frequencies among the elderly and control groups was based on
the Yates-corrected Chi-square test. For continuous variables groups were compared using
the Wilcoxon Rank Sum test for two independent samples with highly unequal variances.
RESULTS AND DISCUSSION
The patient group consisted of 67 males and 130 females, the expected ratio for this age
group. RsaI restriction enzyme analysis (figure 1) performed in the study population
identified one C282Y homozygous female. In table 1 the genotype distribution and allele
frequencies of mutation C282Y in the elderly population are compared with those detected
in the control group. The carrier frequency in the aged was calculated at approximately 1/8,
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compared with 1/6 in those control individuals younger than 30 years of age. These
figures were similar to those found in the general Afrikaner population previously studied
by de Villiers et al. (1999a), and therefore the data obtained in the two control groups were
pooled. There was no statistically significant difference in mutation frequencies between
the elderly and control groups (table 1), or between males and females (data not shown).
Subsequent screening of C282Y heterozygotes for mutation H63D identified two
compound heterozygotes.
The characteristics of 24 C282Y heterozygotes and 1 homozygote identified in the elderly
population are summarised in table 2. The 73-year old woman shown to be homozygous
for mutation C282Y had a ferritin level of 249 ng/ml, which is well above the upper limit
(119 ng/ml) for females, although much lower than that usually encountered (>600 ng/ml)
in patients with clinically manifested HH. Two female H63D/C282Y compound
heterozygotes presented with serum ferritin levels of 162 ng/ml and 242 ng/ml
respectively, which are also above the reference range for females. The ferritin levels in the
C282Y heterozygous group varied between 32 and 1136 ng/ml, with 14 (58%) having a
normal level. In the C282Y-negative group the ferritin levels ranged from 10 to 3942
ng/ml, and 94 individuals (61.4%) had a normal level. The difference between the groups
was not statistically significant and the wide range of serum ferritin levels within each
group implies that this parameter of iron status represents an unreliable indicator of iron-
stores in the body. It is well known that a variety of factors may influence serum ferritin
levels, including any acute or chronic inflammatory disorder which will release ferritin
from affected tissues (Marcus and Freedman 1985), exercise (Lipschitz et al. 1974;
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Malczewska et al. 2000), alcohol use (Lundin et al. 1981), chronic renal failure (Grail et al.
1982), hepatic and ovarian malignancies (Bonazza, 1983) and myocardial infarction
(Birgegard et al. 1979). Since most elderly subjects have multiple age-associated co-
morbidities, serum ferritin may be considered an unreliable measure of body iron-status
particularly in this age group.
RsaI
1 2 3 4
278 bp , 278 bp
116 bp 116 bp
77bp 77 bp
Figure 1. Identification of mutation C282Y in elderly individuals using RsaI restriction
enzyme analysis. Lanes: (1) DNA of a normal control individual, (2) DNA of a C282Y
homozygote, (3) DNA of a C282Y-negative subject and (4) DNA of a C282Y
heterozygote.
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Table 1. Comparison of genotype distribution and allele frequencies of mutation C282Y in
the elderly and control groups
Controls* Elderly
(n=151) (n=197)
Genotype
C282Y++ 3 (2%) 1 (0.5%)
C282Y+- 22 (15%)# 26 (13%)#
C282Y-- 126 (83%) 170 (86%)
Allele
282-G (normal) 0.91 0.93
282-A (mutant) 0.09 0.07
Carrier frequency 16.9% 13%
*102 controls from de Villiers et al. (1999)
#two subjects within each group were compound heterozygotes for mutations C282Y and
H63D
In the control group younger than 30 years of age, the serum ferritin levels ranged from 3.9
to 330.4 ng/ml, all within normal limits. Transferrin saturation ranged from 9.5%
(mutation-negative female) to 55.8% (carrier male). The serum ferritin levels in C282Y
heterozygote males (mean 259.27 ng/ml) were significantly higher (P< 0.01) than in the
mutation-negative male controls (mean 94.89 ng/ml). This finding suggests that young
males may be prone to iron loading in the heterozygous state. All female controls,
including a 24-year old homozygote (24.7 ng/ml) and the four C282Y-heterozygotes (12.8-
16.1 ng/ml) had relatively low ferritin levels. The transferrin saturation levels ranged
between 11.9-45% in the C282Y heterozygotes, while the female homozygote control
presented with a level of 41. 5%.
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Table 2. Characteristics of 1 C282Y homozygote and 24 C282Y heterozygotes identified
in the elderly population
Age Gender Serum Ferritin Transferrin sat Clinical features
(years) (F: 12-119nglml) (F: 15-50%)
(M: 29-396nglml) (M: 20-50%)
C282Y homozygote
73 F 249 ND Type II DM, nm
Colorectal Ca
C282Y heterozygotes
86 F 89 15.7 nm, A, Dementia
74 F 323 16.3 DM, nm, FHx:A
90 F 107 8.8 A
71 F 41 33.7 DM, A, FHx:DM,A
78 F 149 18.1 nm, A, RCa
79 M 217 57.7 Dementia
76 F 238 30.0 FHx:DM,nm,A
74 M 143 9.7 nm, FHx:DM,nm
81* F 242 100 Dementia
86* F 162 ND nm,A
71 F 143 9.8 llID, A, FHx:nm,Ca
70 F 32 ND nm, A, FHx:nm
75 F 52 17.4 A,FHx:A
79 F 78 15.1 DM, nm, FHx:llID,Ca
81 F 319 16.3 DM, nm, FHx:DM, llID,A
76 F 44 11.3 nm, A, FHx:nm,Ca,A
72 F 231 9.6 nm, Ca, FHx:DM,nm,Ca
73 M 88 23.0 DM, nm, A, prostCa,
FHx:llID,A,Ca
86 M 1136 63.6 A, FHx:nm
71 F 157 15.7 llID, A, FHx:Ca,llID
71 F 84 36.5 DM, nm, A, Ca
FHx:DM,nm,A,Ca
77 M 384 25.1 nm, prostCa, A
FHx:llID, Ca
76 M 39 10.8 nm, FHx:nm, Ca
70 M 35 38.7 DM, llID, A, FHx:llID, Ca
*compound heterozygotes for mutations C282Y and H63D
Reference ranges given in brackets for males (M) and females (F)
ND, not determined; llID, ischaemie heart disease; DM, diabetes mellitus Type II; A,
arthritis; FHx, family history; Ca, cancer (of any type)
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The C282Y homozygote presented with type II diabetes mellitus, ischaemie heart disease
and osteoporosis. Family follow-up is under way to determine whether the strong family
history of malignancies (figure 2) reported by the index case (arrow) may be associated
with HH. The C282Y homozygote died of colon cancer approximately six months prior to
completion of the investigation; therefore a repeat sample could not be obtained to
determine a full iron profile of this subject. The two females found to be compound
heterozygotes for mutations C282Y and H63D suffer from ischaemie heart disease and
dementia, respectively. Notably, Moalem et al. (2000) reported a possible role of HFE
gene mutations in dementia. Studies are underway to screen all the mutation carriers for
other known mutations in the HFE gene for further genotype/phenotype association
studies, using a recently-developed reverse-hybridisation teststrip assay (Oberkanins et al.
2000). This assay includes a novel mutation E168Q identified in one of our elderly
Afrikaner individuals with mutation H63D.
The clinical features observed in C282Y -positive (heterozygotes ) and C282Y -negative
elderly subjects are compared in table 3. The group of 24 heterozygotes comprised 7 males
and 17 females between 70 and 90 years old. Differences in iron parameters between
C282Y heterozygotes and mutation-negative subjects were not statistically significant. In
the C282Y heterozygous group there were 12 individuals (3 men and 9 women),with a
combination of any two out of the three clinical "give-aways": diabetes, heart failure and
osteoarthritis; we found only mildly raised serum ferritin levels in three of the women.
The finding that all other iron parameters in these 12 individuals were normal provides an
indication of the non-specificity of these clinical features in relation to HH, particularly in
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the elderly. Among the 33 C282Y-negative individuals that developed a malignancy on
follow-up, 7 (4.6% of the total) were found to have a colon malignancy and 2 an
adenocarcinoma of the rectum (1.3%). A family history of cancer was denoted in 77
persons (50.3%, including the 33 subjects without mutation C282Y), 14 having a relative
with colon carcinoma (9.2%) but none with adenocarcinoma of the rectum. Although the
incidence of diabetes tended to be higher in subjects with mutation C282Y (29% versus
17%), this difference did not reach statistical significance (p=0.2).
I
B
m
IV
2 3
Figure 2. Pedigree of the elderly individual found to be homozygous for mutation C282Y.
Dark-shaded symbols indicate family members who died of colon cancer (1-1,11-3, 11-4, lI-
S) or liver cancer (1-2). Subjects II-I and 11-6 suffered from cardiovascular disease and
asthma, respectively. Subjects 111-1and III-S are regular blood donors.
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Table 3. Comparison of clinical features observed in C282Y-positive (heterozygotes) and
C282Y -negative elderly subjects
C282Y heterozygotes
Total M F
(n=24) (n=7) (n=17)
C282Y negatives
Total M F
(n=153) (n=53) (n=100)
Type IIDiabetes
FHx
29% 2 (29) 5 (29)
25% 1 5
Ischaemie Heart Dis 71% 5 (71) 12 (71)
FHx 100% 5 12
Arthritis 62.5% 4 (57) 11 (64)
FHx 33% 1 7
Malignancy on FlU 21% 2 (29) 3 (18)
FHx 42% 4 6
1 rectum
2 prostate
1 tongue carcinoma
1 myeloma
Serum ferritin range
% with normal level
32 - 1136
58%
17% 8 (15) 18 (18)
32% 9 40
61% 34 (64)60 (60)
77% 37 81
66% 28 (53)73 (73)
41% 16 47
22% 15 (28) 18 (18)
50% 20 57
2 rectum
7 colon
10 - 3942 (ng/ml)
61%
F, female; M, male; FHx, family history
In the C282Y-negative group, 74 people took either acetyl salicylic acid (ASA), warfarin
or some non-steroidal anti-inflammatory drug (NSAID), potentially causing iron loss due
to gastrointestinal bleeding. Normal ferritin levels were present in 53 (71.6%) of these
subjects, versus 51 out of 79 non-takers (64.6%). Of the 21 individuals whose levels were
raised, 10 (47.6%) had levels -double the normal, in 5 it was ~3 times the normal and in
one person the level was elevated to 5 times above normal parameters. As discussed above,
factors such as liver disease, malignancy, haemolysis and a host of inflammatory
conditions may cause elevation of the serum ferritin concentration, but the levels of this
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acute phase protein does apparently not change significantly in the case of probable blood
loss. Blood loss is much more frequent in elderly subjects using ASA, warfarin or a
NSAID than in the younger population taking the same medications. The usefulness of
serum ferritin determination is thus probably limited to the follow-up of individuals with
established disease. The group of C282Y -negatives that developed colon carcinoma
consisted of 5 women and 2 men, all with serum ferritin levels within the normal range;
only 2 took ASA. The two patients with rectal carcinoma also had normal levels and took
no ASA.
It is noteworthy that none of the males included in this study were homozygous for
mutation C282Y, while Willis et al. (1999) detected four homozygous males in their group
of 600 elderly men studied. Besides the possible selection bias reported in this test group as
a consequence of possible haemochromatosis-related diseases, it is possible that some of
these subjects were mistyped as a consequence of anMse! polymorphism in intron 4 of the
lIFE gene, as described for one of the elderly Afrikaner subjects initially diagnosed with
putative RH by de Villiers and Kotze (1999). The detection of a single female C282Y
homozygote in our study population may also be a related to early death in Afrikaner men
with the RH genotype. The daily diet of most Afrikaners (particularly males) contains a
considerable amount of red meat and relatively few green vegetables, thus promoting iron-
loading. Garry et al. (1997) were also unable to identify any C282Y homozygotes among
287 healthy elderly volunteers, although seven subjects were compound heterozygotes for
mutations H63D and C282Y (2.4%). We noticed the similarity in C282Y heterozygote
frequency (11. 8%) and compound heterozygote frequency (1. 1%) in our study population,
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but the lack of H63D-homozygosity probably reflects the influence of genes from
Hispanic origins in this population of New Mexico. It has been well described that in these
populations the frequency of H63D is much higher than in people of Celtic descent
(Sánchez et al. 1998). The absence of C282Y homozygotes could be due to selection bias
as this group consisted of healthy volunteers, but one can also presume that those with high
iron stores had an increased mortality rate and the findings may therefore be the result of a
natural selection process.
In conclusion, we have demonstrated that the C282Y mutation occurs in aged Afrikaners
albeit at a slightly lower frequency than in the younger population from the same gene
pool. It therefore appears to be unlikely that one or two mutant alleles for RH confer a
survival advantage for the aged, which may be envisaged for multiparous women as a
means of keeping up their iron-stores (Datz et al. 1998). This study underscores the
difficulties of clinical diagnosis in the absence of a reliable laboratory assay, as the general
clinical picture in older individuals is characterised by non-specific symptoms associated
with RH and a high background frequency of those diseases that can cause the symptom-
complex specific for RH (type II diabetes, heart failure, osteoarthritis). As multiple factors
are known to influence both the serum iron and ferritin values, these biochemical tests are
probably of limited value in RH diagnosis, particularly in the elderly. In our random
sample of elderly subjects no relationship was found between possession of mutation
C282Y and the development of colorectal malignancies, although the single female C282Y
homozygote died of colorectal cancer. Failure to indicate a significant association with
cancer may be due to the relatively high incidence of colorectal neoplasia in this age group,
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and/or the likelihood that C282Y homozygotes with relatively high serum iron levels died
before reaching their seventies. A prospective study of the cohort of young individuals
included in the study might in future provide valuable information in this respect.
Individuals with normal iron status despite a genetic predisposition for HH (Rhodes et al.
1997; Adams, 2000) who survive into old age can be expected to harbour modifier genes
(Rhodes et al. 1997; Whitfield et al. 2000) that guard them from iron overload.
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CHAPTER4
Conclusions and Future Prospects
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4.1 Conclusions
In this study a sample of elderly Afrikaner citizens has been tested for the presence of the
most common mutation (C282Y) underlying hereditary haemochromatosis (RH) in
association with possible iron overload. The clinical picture associated with HH is non-
specific in nature, and analysis of the elderly emphasised the difficulties of clinical
diagnosis of this common autosomal recessive disease. Attempts to identify HH in patients
presenting with type II diabetes mellitus did not indicate a higher rate of detection
(Sampson et al. 2000; Turnbull et al. 1997), although in a group of individuals presenting
with arthropathy the prevalence was found to be 5 times the population prevalence at 1.5%
(Olynyk et al. 1994). However, in a document produced by the European Association for
the Study of the Liver (EASL) International Consensus Conference on HH, it was clearly
stated that ''both diabetes and rheumatological diseases are so frequent in the general
population that these conditions can easily be over-interpreted as belonging to the
phenotypic expression of haemochromatosis". Large-scale epidemiological studies are
therefore needed to determine the sensitivity and specificity of the components of the
clinical picture in predicting the likelihood of underlying HH genotypes.
This study has shown that the discrepancy between the genotype findings on the one hand
and serum iron concentration and phenotype on the other, which has been described
previously in adults (Adams et al. 1997; Edwards et al. 1998; Olynyk et al. 1999; Whitfield
et al. 2000), does persist in our aged population. Generally however, iron levels are lower
than expected, either because those with raised iron stores have died before reaching their
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seventies, or they belong to a group of individuals who do not express homo- or
heterozygosity for mutation C282Y (Adams, 2000). Reasons for this non-expression are as
yet speculative but could be related to environmental factors such as a low-iron diet and/or
gene-gene interaction resulting in incomplete penetrance of a HH mutation due to
protection against iron loading.
With regard to the biochemical tests of iron status, serum ferritin was found to be a rather
non-specific measure of body iron stores and this parameter is therefore not recommended
as a marker in this age group. Raised serum ferritin in the elderly may therefore be a
confounder, i.e. an indicator of an underlying disease such as an inflammatory process or
atherosclerosis, rather than of iron loading. Moreover, metabolic disorders have been
described that manifest with significant iron overload but with a normal transferrin
saturation and the wild type HFE gene (Moirand et al. 1997). These patients were
significantly older than those with HH and had one or more of the following conditions:
obesity, hyperlipidaemia, abnormal glucose metabolism and hypertension.
As serum iron has also been found to be unreliable (Nodtvedt et al. 2000), the total iron
binding capacity is probably the most reliable parameter for HH screening in the elderly, as
has also been advocated for younger adults (Hickman et al. 2000). Even in the group of
heterozygotes identified in this study only two individuals with a serum transferrin
saturation above the upper limit of 50% were detected. This finding confirms a report by
Franzini et al. (2000), indicating that transferrin saturation is lower in the aged and that
those with significant iron loading have probably already died. However, one of the
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compound heterozygotes with both mutations H63D and C282Y presented with a serum
transferrin saturation concentration of 100%. Unfortunately the serum transferrin saturation
could not be determined in the second compound heterozygote or the C282Y homozygote
for comparative analysis. The serum ferritin values of these individuals with HH genotypes
were above the reference value (396 ng/ml, range 162-249 ng/ml), although lower than
expected in HH (usually >600 ng/ml). Investigations are underway to perform follow-up
studies in family members of the C282Y homozygote, to determine whether the strong
family history of cancer in this family can be ascribed to iron overload due to the presence
of mutation C282Y.
Our increasing understanding of the molecular basis of genetic disorders of iron
metabolism in mammalian species is providing new insight into genes involved in
mediating intestinal iron absorption. It has become clear that the control of iron
metabolism is interconnected with other cellular pathways, and further analysis of these
aspects are likely to provide a better understanding of pathological processes (such as
radical-mediated tissue damage or neurodegenerative disease) in which iron may
participate. Over the past 3-4 years new technology enabled the identification of an
increasing number of iron-related genes (by positional cloning strategies) from humans or
animals with known genetic defects in intestinal iron absorption. Genome research and
bioinformaties undoubtedly offer significant promises towards elucidating the genetics of
molecularly uncharacterised conditions that may be caused by a disturbance in iron
metabolism. It also provides the necessary tools to identify many different genes
underlying a well-defined phenotype, previously considered to be caused by a single gene.
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4.2 Future Prospects
Genetic analysis of patients with HFE-associated RH has revealed a complex spectrum of
phenotypic expression. Although there is no doubt that the C282Y mutation in HFE is a
disease-causing mutation, there is a small subgroup of C282Y homozygotes who does not
develop clinically significant iron overload. On the other hand, some C282Y homozygotes
develop severe iron overload early in life, and some C282Y heterozygotes develop
haemochromatosis, indistinguishable from the picture of the homozygotes. This variability
cannot be explained by environmental factors alone (Whitfield et al. 2000), and therefore
the existence of other modifier genes that influence the RH disease phenotype is the most
probable alternative. There are likely to be a number of genes with individual small and
additive effects. Location of such genes may be achieved through association studies of
candidate genes or it may require a genome-wide search.
Screening of healthy C282Y homozygotes for genes that may interact with the HFE gene,
thereby resulting in possible non-expression of the RH phenotype, may lead to the
identification of genes underlying iron deficiency and/or protect against iron
overload/organ damage. One of the genes that are likely to interact with the HFE gene is
the human divalent metal transporter (DMTI), identified as a possible cause of inherited
iron deficiency anaemia (Fleming et al. 1997; Vulpe and Gitschier, 1997). This gene was
previously known as the natural resistance-associated macrophage protein-2 (NRAMP2)
gene (Vidal et al. 1995). Only one of the elderly individuals with mutation C282Y tested
positive for a novel splice site mutation recently identified in the DMTI gene (R
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Hillermann and JNP de Villiers, unpublished results). Although the heterozygote frequency
of this variant IVS2+6t~g was similar in the elderly and younger adult groups, further
studies are warranted to investigate the likelihood that this mutation affects normal splicing
of the DMT1 gene, thereby affecting serum iron status in the general population.
The human NRAMP 1 gene that shows a high degree of sequence homology to
DMT 11NRAMP2, represents another candidate gene that may affect iron homeostasis in
humans. This gene is involved in the regulation of iron and is in tum also regulated by
iron. Interestingly, we have shown that the allelic distribution of the Z-DNA forming
repeat length polymorphism in the promoter region of the NRAMP 1 gene differs
significantly between the elderly Afrikaner population compared with younger controls
(Kotze et al. submitted/Appendix B). This finding confirms the previous speculation
(Searle and Blackwell 1998) that certain detrimental NRAMP1 alleles related to
autoimmune disease susceptibility, may be maintained in the population because they
improve survival to reproductive age following infectious disease challenge. This may
imply that NRAMP1 alleles found to predominate in the elderly may confer protection
against infection, iron overload and/or oxidative processes implicated in aging. Iron
deficiency anaemia was evident in the two elderly males (ferritin 12 ug/l and 39 ug/l,
transferrin saturation 10.8% and 16.5%) with this genotype, while higher levels were
measured in the elderly female (ferritin 273 ug/l, transferrin saturation 20%) with alleles 3
and 5 of NRAMP 1. It is noteworthy that the male with the lowest transferrin saturation
level was heterozygous for mutation C282Y.
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Animal models provide another means of identifying genes that may modify the
haemochromatosis phenotype, although this should subsequently be verified in humans.
Levy et al. (2000) have bred lIFE knockout mice with strains carrying other mutations that
impair normal iron metabolism. Compound mutant mice lacking both lIFE and its
interacting protein, 132microglobulin, deposited more tissue iron than mice lacking lIFE
only. lIFE knockout mice carrying mutations in the iron transporter DMT1 failed to load
iron, indicating that haemochromatosis involves iron flux through DMTl. Similarly,
compound mutants deficient in lIFE and hephaestin showed less iron loading than do lIFE
knockout mice alone, suggesting that iron absorption in haemochromatosis involves the
function of this gene as well. Finally, compound mutants lacking lIFE and the transferrin
receptor accumulated more tissue iron than did mice lacking lIFE alone, consistent with
the idea that interaction between these two proteins contributes to the control of normal
iron absorption. In addition to providing insight into the pathogenesis of lllI, these results
suggest that many different genes might influence iron homeostasis in humans.
Elderly subjects from the genetically homogeneous Afrikaner population provide a
valuable source of material for a study aimed at the delineation of gene-gene and/or gene-
environment interaction in lllI. The 74-year old Afrikaner female identified in this study
with two copies of mutation C282Y, can be expected to harbour gene(s) that protect
against iron overload. Elderly subjects with haemochromatosis genotypes (Willis et al.
1999) will in future be subjected to extensive molecular analysis to identify
genes/mutations that may underlie iron deficiency/protection against iron overload within
the South African context. Determination of the incidence of clinical/biochemical
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misdiagnoses in HH may lead to a better definition of clinical criteria for diagnosis of HH,
and ultimately, the development of a comprehensive DNA-based test for accurate
assessment of iron status in South African subjects. Mutation analysis in the elderly
subjects recruited for the current study will in future be extended to screening of the TFR2
gene, recently implicated as a second locus for adult-onset haemochromatosis
(Camaschella et al. 2000).
Since mutation accumulation late in life can only be identified by studying the elderly,
future studies aimed at the identification of iron-related genes that exert both an age-
dependent negative and a positive effect on survival may increase our understanding of the
role of iron in health and disease. We indeed have much to learn from our elders.
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APPENDIX A
LABORATORY PROCEDURES
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The laboratory procedures used for this work consisted of four different phases:
1. Genomic DNA-extraction
2. Polymerase Chain Reaction
3. Restriction Enzyme Digestion
4. Gel Electrophoresis
1.1 GENOMIC DNA-EXTRACTION
General guidelines:
• EDTA-preserved blood is needed (10ml)
• Always use your own and fresh reagents
• Beware of tissue contamination
Protocol:
1. After proper shaking, the EDTA-blood is placed in a 50ml Falcon tube, the EDT A-
tubes are kept for back-up and the Falcon tubes are numbered (top and side).
2. Add cold lysis-buffer, up to a volume of 45 ml and shake well ( solution will
become turbid).
3. Put the tubes in the fridge for about 10 minutes until the solution is translucent.
4. Centrifuge at 1500 rpm for 15 minutes, then carefully remove the supernatant so
that the pellet with white blood cells (WBC) remains in the Falcon tube.
5. Rinse the pellet carefully with 10 ml phosphate buffered saline (PBS) from the
fridge and carefully remove supernatant. Do not disturb WBC pellet.
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6. Add 3 ml of nuclei lysis buffer, 30 III proteinase-K and 300 Ill. of a 10% sodium
diodocyl sulphate (SDS)-solution and mix by vortexing.
7. Incubate the tubes in a 55°C waterbath, overnight.
8. Add 1ml of6 M NaCI the next morning and shake vigorously for about one minute.
9. Centrifuge for 20 minutes at 2500 rpm to pellet the cellular debris and pour the
supernatant off immediately.
10. Add 2 volumes 100% Ethanol from the freezer to precipitate the DNA and proteins.
Il. Carefully remove the DNA and wash in 1.5ml 70% ethanol.
12. Centrifuge for 30s at 13000 rpm and remove the supernatant.
13. To vaporise the ethanol, leave the pellet in the tube for 10 minutes, exposed to the
air to dry.
14. Reconstitute the DNA pellet in Iml SABAX sterile water and shake on mechanical
shaker until the whole pellet is dissolved.
1.2 POLYMERASE CHAIN REACTION
General Guidelines:
• First clean the whole area, gloves and all the racks with hibitane
• You always need to have a positive control, a negative control and a placebo-
control to ensure that the polymerase chain reaction (PCR) has worked and was not
contaminated.
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Protocol:
For each PCR a 25 ul reaction volume is used containing the DNA, Taq Polymerase,
buffer, dNTPs, forward and reverse PCR primers and sterile water. The mixture has to be
mixed on the Vortex for a few seconds. The oligonucleotide primers are 18-22 base-pairs
long and homologous to the known DNA sequence. Taq Polymerase is stored in glycerol
to prevent freezing and so will form a little "cloud" upon adding to the cocktail. Its optimal
temperature is 72° C, but will survive 95° C, with some reactivity at a low 20° C.
The PCR program consists of repeated cycles: denaturation, where the double-stranded
DNA is separated into two single strands by heating at 95° c., then annealing of the
primers on the strands by lowering the temperature to 55°C (the annealing temperature of a
primer depends on the GATC-content: Tm= (4x [G+C]) + (2x [A+T]), and finally
extension. For the primers used in this study the optimal annealing temperature is 65°_
68°C. The extension time depends on the length of the template.
PCR-Program for exon 4 of the lIFE gene:
Incubate at 95°C for 2 min, then start the 1st cycle:
95°C -10 seconds }
65°C -10 seconds } FOR 10 CYCLES
72°C -30 seconds }
95°C -for 10 seconds }
60°C -for 10 seconds }
72°C -for 30 seconds}
FOR 25 TO 30 CYCLES.
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1.3 RESTRICTION ENZYMEDIGESTIONOF PCR PRODUCTS
For digestion with restriction endonucleases a cocktail is prepared:
1) l Oul DNA (too much DNA will hamper analysis)
2) 2 ul of lOX buffer
3) 7.5JlI. sterile water
4) 0.5Jll of enzyme-solution (containing 5-10 Units of enzyme to ensure full digestion;
this must be less than 10% of the total volume, as the glycerol in the enzyme-
solution may inhibit digestion.
RsaI has a specific recognition site (GT/AC) and cuts the normal 394-bp exon 4 into
278bp- and 116-bp fragments. In the case of the C282Y mutation a new cutting site is
created by this G to A mutation at nucleotide position 845, where GTGC changes to
GT4C. This leads to the digestion of the smaller 116-bp fragment into two fragments. In
the case of a C282Y heterozygote three DNA fragments will be visible on the gel (278bp,
116bp and 77bp), and in the case of a homozygote only the 278bp and 77bp fragments will
be observed.
The mixture can either be left overnight or for 2 1;2 hours in a 37° C water bath to undergo
optimum digestion. Check temperature with two thermometers (mercury and alcohol).
1.4 POLYACRYLAMIDEGEL-ELECTROPHORESIS
To assemble the Hoefer SE600 gel-apparatus:
1. Place four glass plates alongside one another and in a horizontal position on the table.
2. Clean the glass plates and the spacers with wet tissues and dry.
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3. Grease the spacers on one side to prevent current-leakage.
4. Assemble the plates and spacers, ensuring that the upper borders are at the same level,
and secure the structure by applying clamps. Tighten it using the clamps.
5. Place assembled glass plates in gel pourer container.
6. Melt agarose (2%) for 3 min at full power in microwave. Pour enough agarose in the
container so that a small (lcm) plug is formed at the bottom between the glass plates.
Tighten plates by using tightening knobs.
GELMIX (20 ml in total for a gel of 15 x 15 cm.):
1) 7 ml polyacrylamide (3.4% cross link, 30% stock)
2) 4 ml5 X TBE-buffer (tris-boric acid and EDTA)
3) 9 ml sterile water
4) 160 I.il. APS (ammonium persulphate)
5) 80 JlITEMED (tetra-methyl-ethilene-diamine or N,N,N' ,N')
The concentration of the gel will determine its power to separate fragments of different
size. The gel mix is poured in the 0.75 mm cavity between the glass plates. The agarose
prevents the gel mix from leaking by forming a gel barrier. Care must be taken that no
bubbles are formed, as this will affect the results and DNA mobility. A comb is inserted at
the top of the gel between the plates so that after polymerisation and removal of the comb,
cavities are created for loading the DNA samples. Upon removal of the comb, rinse the
cavities with IX TBE buffer to clear out all possible debris. Prepare the DNA samples by
adding 5 I.il of blue loading buffer, the reasoning for this being:
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DNA is weighed down so that when loaded into the cavities, it does not float out. The blue
stain acts as a marker that migrates with known DNA fragment sizes. Load 151-11of the
sample in the formed cavities together with an uncut control sample and DNA marker.
Assemble gel apparatus by adding and fastening the top buffer chamber and add 1X
running buffer up to a maximum level and apply current (250 V for 2 hours). Run gel until
only the light blue band is visible.
Remove glass plates from apparatus and separate so that the 0.75 mm gel is exposed. Stain
gel for 10 minutes in a 1X TBE solution containing ethidium bromide. Destain for 2
minutes in distilled water to remove excess ethidium bromide that may cause background
staining. The gel is placed on a trans illuminator and exposed to UV light for 2 seconds
upon which a photograph is taken using a CCD camera. The photograph is printed and the
gel analysed by comparing the resulting band sizes with controls loaded on the same gel.
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ABSTRACT
Multiple sclerosis (MS) is believed to be an autoimmune process occurring in genetically
susceptible individuals after an appropriate environmental exposure. We have exploited the
homogeneous Afrikaner population of European ancestry to investigate the likelihood that
iron dysregulation, in association with infectious and/or autoimmune disease susceptibility,
may underlie the MS phenotype in a subgroup of patients. The functional Z-DNA forming
repeat polymorphism of the natural resistance-associated macrophage protein-1
(NRAMP1) gene was analyzed in 104 patients diagnosed with MS and 522 Caucasian
controls. A family-based control group consisting of 32 parental alleles not transmitted to
MS offspring was additionally studied to exclude the likelihood of population
substructures. Statistically significant differences in allelic distribution were observed
between the patient and control samples drawn from the same population (P<O.Ol).
Evidence is furthermore provided that alleles considered to be detrimental in relation to
autoimmune disease susceptibility may be maintained in the population as a consequence
of improved survival to reproductive age following infectious disease challenge. Although
it remains to be determined whether the disease phenotype in MS patients with allele 5 of
the NRAMP1 promoter polymorphism is directly related to dysregulation of iron or
modified susceptibility to viral infection and/or autoimmunity, a combination of these
processes most likely underlie the disease phenotype in these patients. In view of the
emerging role of polymorphic variants in complex diseases and minimizing of possible
confounding factors in this association study, we conclude that allelic variation in the
NRAMP 1 promoter may contribute significantly to MS susceptibility in the South African
Caucasian population.
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INTRODUCTION
The cause of multiple sclerosis (MS), a chronic inflammatory disease of the central
nervous system (CNS), remains unknown after more than a century of study. Current
knowledge suggests that MS is associated with autoimmunity, with genetic susceptibility
and infectious agents as important risk factors (1,2). The overall lifetime risk for siblings of
MS patients to manifest the disease is estimated at 4-5%, compared to a population
prevalence of approximately 0.1%. Although data on family studies have excluded all but a
. polygenic mode of inheritance, and an autosomal dominant or recessive single locus with
low penetrance, most evidence suggests that several genes control disease susceptibility
(3). Autopsy studies in a cohort of MS patients indicated four fundamentally different
patterns of demyelination, suggesting pathogenetic heterogeneity with important
implications for the diagnosis and treatment of the disease (4).
Previous genome-wide gene searches and association studies suggest that the
genetic susceptibility factors ofMS may vary between different populations (3). The white
Afrikaner population of South Africa represents an ideal group (5) for the identification of
genes involved in this complex disease, since the prevalence of MS is relatively high in the
European populations that contributed to the gene pool of this genetic isolate. Earlier
studies indicated a relatively low incidence (--0.4/100 000) of the disease in the Caucasian
population of South Africa (6), but more recently Dean (7) reported that the prevalence of
MS is on the increase in the Afrikaner population. Although the Afrikaner population is
mainly of Dutch, German and French origin, settlers from the United Kingdom with a
relatively high prevalence (12/100 000) of MS amongst Scottish individuals (8), have also
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made a considerable contribution (~5%) to the gene pool (9). The uruque genetic
background of the Afrikaner population therefore offers the advantage to study the genetics
of MS on the basis of an expected limited number of disease-associated genes/mutations
introduced from Europe. Genetic analysis in the African context furthermore provides the
opportunity to assess the relevance of potentially important sequence changes III
indigenous population groups, where MS is considered to be extremely rare (10).
The importance of genetic factors underlying population/ethnic differences III
disease risk was illustrated by the finding that the hereditary hemochromatosis (llli)
mutation C282Y in the HFE gene (11), associated with this cornmon iron overload disease
in the majority (70-100%) of affected Caucasians worldwide, is virtually absent in the
South African Black population (12). Of relevance to this study is the apparent absence of
clinically manifested Hrl among 1700 patients with MS encountered by Valberg et al. (13),
despite the higher serum ferritin levels detected in patients compared with controls and the
fact that MS and Hlf affect the same ethnic group. Similar findings were reported in an
Afrikaner family where two sisters with MS were found to be homozygous for the
cornmon Hlf mutation C282Y (14), which largely excluded the likelihood of a linkage
disequilibrium effect with a putative MS-related gene on chromosome 6. These findings
raised the possibility that MS and RH may be mutually exclusive due to gene-gene
interaction in certain populations.
There are several lines of support for a role of iron dysregulation in the
pathogenesis of MS (15-20). This pertains to the fact that iron overload may predispose an
individual to virus infection, whilst on the contrary, inadequate supply of iron may impair
immune function. To further investigate the potential role of iron metabolism in
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association with infectious and/or autoimmune disease susceptibility in MS, we genotyped
104 South Afiican MS patients and 532 control individuals from the same population for
the functional Z-DNA forming repeat polymorphism of the natural resistance-associated
macrophage protein-1 (NRAMP 1) gene. This gene that regulates iron, and is also regulated
by cellular iron levels (21), has been linked to many infectious and autoimmune diseases
(22-25). Although these findings may be related to anyone of the multiple pleiotropic
effects associated with macrophage activation, it seems highly likely that regulation of iron
transport via NRAMP1 may contribute directly to disease susceptibility (23). Some of the
diseases associated with the NRAMP1 gene may pathogenetically be related to MS (26-30)
and apparently also to abnormalities in iron absorption (31,32), that may be linked to
defective iron supply for erythropoiesis (33). The anemia associated with autoimmune
disease may be related to the proposed role ofNRAMP1 in scavenging iron from senescent
red cells via splenic macrophage phagosomes for transport back to the blood.
MATERIALS AND METHODS
Study population. Relevant information was obtained from 281 South Afiican patients,
following the distribution of a questionnaire that was published in the South Afiican
National Multiple Sclerosis Society newsletter. Blood samples were obtained, after
informed consent, from 156 South Afiican respondents who completed the questionnaire
and 197 of their close relatives. The patients' neurologists were subsequently contacted to
verify the MS diagnoses, based on clinical features (34), lumbar puncture, magnetic
resonance imaging, evoked potentials and/or exclusion of other diseases known to manifest
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similarly. Uncertain cases included in the study were re-examined by J.c. Non-Caucasian
South African MS patients, recent immigrants, and respondents without a confirmed
diagnosis of MS were excluded from the study, leaving 104 index cases diagnosed with
definite MS for genetic analysis.
DNA samples of 329 South African individuals of European descent (mainly
German, Dutch, French and British) below the age of 70 years were included as unrelated
controls. The individuals consisted of 231 laboratory personnel and medical students (68
males and 163 females), and 98 spouses of patients with MS (16 males and 13 females) or
familial hypercholesterolemia (34 males and 35 females). Additionally, 193 elderly
individuals above the age of 70 years (67 males and 126 females) and a family-based
control group consisting of 32 parental alleles not transmitted to MS offspring were
included for comparison within and between subgroups. Inclusion and exclusion criteria
were similar in the experimental and control groups. MS patients and controls found to be
homozygous for the Ill-I mutation C282Y were excluded from this study. Data obtained on
laboratory personnel, medical students and spouses of index cases were pooled with the
"affected-family-based control" (AFBAC) group (35) after verification of similar allele
frequencies in the different groups. DNA samples from 448 non-Caucasians (278 Xhosas,
50 KhoiSan and 120 subjects of Mixed Ancestry), 37 healthy Scottish individuals and 143
Germans were included as controls for population studies. Matched case-control groups are
particularly important in diseases such as MS where environmental triggers may be
involved. The study protocol has been approved by the Ethics Review Committee of the
University of Stellenbosch.
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Hematological and Biochemical analysis. Hemoglobin, serum iron, transferrin and
ferritin concentrations were determined using standard methods. Serum iron was measured
with a Beckman CX7 auto analyser, and transferrin with a Beckman Array Nephelometer.
Transferrin saturation was subsequently calculated. None of the patients analysed
experienced episodes ofMS at the time iron concentrations were determined.
DNA analysis. Genomic DNA was isolated from whole blood using a standard salting-out
method (36). The PCR primers used to amplify a 483-bp fragment of the NRAMPI
promoter were 5'-GGGGTCTTGGAACTCCAGAT-3' (forward) and 5'-
GGGCAGCTCCTCAGCCTGCAC-3' (reverse). The PCR conditions were as follows: 200
ng of genomic DNA, 0.2 flM of each dGTP, dCTP, dATP, dTTP, 20 pmol of each primer,
1.5 mM MgCh, 10 mM Tris.HCI, 50 mM KCI and IU Taq DNA Polymerase. PCR cycle
conditions included an initial denaturing step at 95°C for 2 minutes, followed by 35 cycles
at 95°C for 30 seconds, 65°C for 45 seconds, and 72°C for 30 seconds. Screening ofPCR-
amplified DNA for potential disease-related mutations was performed using a combined
HEX-SSCP method according to Kotze et al. (37). PCR products corresponding to aberrant
bands were sequenced using an automated system (AB! 310, Perkin Elmer Applied
Biosystems). For better discrimination between different alleles of the (gt)n repeat, Rsa!
restriction enzyme analysis was performed according to Graham et al. (25). Following the
amplification of a shorter ll6-bp fragment using a new reverse primer 5'-
TACCCCATGACCACACCC-3', PCR products were digested to completion with Rsai,
subjected to polyacrylamide (PAA) gel-electrophoresis (12% PAA, 5% C), stained with
ethidium bromide and visualized by ultraviolet light.
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Statistical methods. NRAMP1 allele frequencies were analysed by STATISTICA for
Windows (38), which offers different statistical methods to determine significant
associations. The Chi-square (X2) test and/or Fisher-exact test were performed to assess
significant associations with NRAMP1 in the study population. Due to the low frequency
of certain variants in the study population, the Yates' correction was applied to improve
the approximation of the X2- test, thereby providing a more conservative estimation. The
Arlequin program (39) was used to test for various associations of polymorphic variants in
the disease and control populations. This program assesses the likelihood that false
associations may be obtained due to population substructures. For continuous variables
groups were compared using unpaired t tests. The Wilcoxon (Kruskal- Wallis) and median
tests were used for variables (ferritin) with skew distributions.
RESULTS
Serum iron parameters
Iron parameters were determined in 34 South African MS patients with relapsing-remitting
(RR) MS, 10 with secondary progressive (SP) MS and 9 with primary progressive (PP)
MS. Similar to that of a control group including 30 Caucasian individuals, the hemoglobin,
serum iron, transferrin, transferrin saturation and ferritin values were within the normal
range in the majority of cases. The serum ferritin concentration was significantly lower in
the RR group than in the PP group (p<0.05), but none of the other parameters tested
differed between the three patient groups (Table 1). When males are excluded, the
statistical significance disappears even though the trend remains the same (RR 71.61lg/l,
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SP 88.0 ug/l, pp 109.6 ug/l). The patients with the progressive illness showed greater
variability in ferritin levels. Patients with a RR disease course were the youngest on
average (P<0.08). The age at onset was also the youngest in the RR MS group (29.5, SD
9.6), followed by the SP (34.3, SD 11.1) and PP (35.3, SD 6.8) groups.
Analysis of the functional Z-DNA forming NRAMPl repeat polymorphism
Many variants have been described in the NRAMPI gene, one of which is a functional Z-
DNA forming repeat promoter polymorphism affecting NRAMPI expression (22). The
different alleles detected within the amplified DNA fragment spanning this polymorphic
region are shown in Table 2, together with the allelic distribution observed in South
African Caucasian MS patients and controls drawn from the same population. The allelic
distribution of the Z-DNA forming dinucleotide polymorphism differed significantly
between the MS patients and population-matched controls (P<O.OI), including 329
individuals from the general population within the same age group, a family-based control
(AFBAC) group including 32 parental alleles not transmitted to MS offspring, and 193
elderly Afrikaner individuals above the age of 70 years. Although the sample sizes of the
different subgroups analysed are relatively small, no population substructures were evident
upon application of the Ewens-Watterson test of selective neutrality and the Chakraborty's
test for population amalgamation (39). The genotype distribution and allele frequencies of
the NRAMPI promoter variant were in Hardy-Weinberg equilibrium in the populations
tested.
Genotyping of the 193 elderly Afrikaner individuals from the general population
also indicated a significant deviation from the younger control group (P<O.OI) (Table 2).
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This finding suggests that alleles considered to be detrimental in relation to autoimmune
disease susceptibility may be maintained in the population because they improve survival
to reproductive age following infectious disease challenge (22), a phenomenon that may be
of particular relevance in the African context. This may imply that alleles 3 and 5 found at
a higher frequency in the elderly group compared to younger controls might confer
protection against infection, iron overload and/or oxidative processes implicated in aging.
Iron deficiency anemia was evident in the two elderly males (ferritin 12 ug/l and 39 ug/l,
transferrin saturation 10.8% and 16.5%) with this genotype, whilst higher levels (ferritin
273 ug/l, transferrin saturation 20%) were measured in the elderly female with alleles 3
and 5 ofNRAMPl.
The clinical characteristics of the index MS patients with allele 5 are summarized
in Table 3, together with that of two affected female relatives with this allele who were
also diagnosed with definite MS. Extended clinical and family follow up are underway to
clarify the potential role ofNRAMP1 in the MS phenotype.
Population studies
NRAMP1 allele 5 was not detected in Africans following DNA screening of 278 Xhosas,
50 KhoiSan and 120 subjects of Mixed Ancestry. This finding is in accordance with the
potential significance of allele 5 in MS, since this disease is extremely rare in Africans
(10). Population and haplotype studies using intragenic NRAMP1 polymorphisms are in
progress to trace the origin ofNRAMP1 allele 5 in European populations that contributed
to the Afrikaner gene pool. Preliminary data obtained in DNA samples of healthy Scottish
individuals indicated a significantly higher frequency (2/37, 5.4%) of NRAMP1 allele 5 in
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this population compared with the general Afrikaner population (0.3%) (P<O.OI, 2 d.f
X2=14.33), while an intermediate frequency was observed in the German population
(3/143,2.1%). These findings raise the possibility that NRAMPI allele 5 may be one of the
factors underlying the high prevalence (8) of MS in Scotland. Approximately 15% of the
104 South African MS patients (1/7 with allele 5) included in this study reported that at
least one of their ancestors was of Scottish descent.
DISCUSSION
Iron is an essential nutritional element for normal cellular functioning of a large number of
enzymes, including those involved in myelin formation, neurotransmitter synthesis and
degradation, oxidative phosphorylation and heme biosynthesis (40-42). Hemeproteins are
involved in electron transport, which could be critical to axonal as well as to myelin
integrity. The human NRAMPI gene was analysed in this study as a first candidate to
investigate the hypothesis that intermittent iron deficiency (19) may underlie the MS
phenotype in a subgroup of patients. The potential value of iron concentration
determination in the cerebrospinal fluid (eSF) in distinguishing between MS patients with
different disease courses has been demonstrated (16,17), and this may also apply to
determination of serum iron parameters (20). Preliminary data furthermore indicated a
significantly higher mean serum ferritin concentration in the South African patient group
compared to controls (data not shown), which is in accordance with previous findings (13).
This difference remained statistically significant when only·females were compared, and in
this group mean transferrin saturation was lower in patients compared with controls,
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although the values were within the normal range in both groups. The statistically
significant differences in NRAMP 1 allelic distribution observed between MS patients and
control individuals drawn from the same population (P<O.01) are in accordance with
possible involvement of iron metabolism in the pathogenesis of MS. Notably, different
cellular iron levels in Nrampl wildtype (low) versus mutant (high) macrophages in mice
may affect mRNA stability for WIe class II molecules (23), which highlights the link
between iron metabolism and cell-mediated immunity (43). The enhanced responsiveness
of Nramp 1 wildtype macrophages to a range of biological stimuli (44), including bacterial
lipopolysaccharide (LPS), interferon-y, glucocorticoids such as dexamethasone or
cortisone (frequently applied in the treatment ofMS), may relate to the enhancer activity of
the Z-DNA forming dinucleotide repeat (22) analysed in this study.
The functional significance of the NRAMPI promoter polymorphism analysed
argues against the likelihood that the increased frequency of the potentially functional Z-
DNA variant in South African MS patients is due to association with another mutation in
the NRAMP 1 gene or a nearby gene. Sequence changes which directly affect the gene
product are more likely to demonstrate genetic and phenotypic differences between patient
and control samples than indirect markers, particularly if it is present in only a small
proportion of the study population as demonstrated in this study. This may explain why
previous investigators failed to identify human chromosome 2q as a potentially important
region in whole genome screens for MS and highlights the potential involvement of
separate candidate loci in different populations (3). Association studies appear to be of
greater power than linkage analysis in genetic studies of complex human diseases (45),
since associated (disease-predisposing) polymorphisms are not necessarily linked to a
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disease. A mathemathical explanation for this phenomenon has been provided by
Greenberg (46), which emphasizes the fact that the detection of certain alleles (usually at a
lower frequency) in a control population does not exclude the likelihood that the sequence
change may cause or contribute to the disease phenotype. MS is considered to be a
heterogeneous disease (4, 47) where many different genes may be defective. Consistent
linkage to the Hl.A region on chromosome 6 (47) in different genomic data sets and
different populations may be related to possible polygenic control of MS, where disease
susceptibility in conjunction with environmental factors is determined by non-MHC genes
and disease severity/course by modulation of T cell responses to particular antigens, much
like the situation described in mice (48). Interestingly, Jacobsen et al. (49) have recently
demonstrated an association between MS and the gene (PTPRC) encoding protein-tyrosine
phosphatase, receptor-type C (CD45), known to be essential for the activation of Tand B
cells.
The many cellular functions dependent on iron and other metal ions as cofactors
may explain the complex role of NRAMP 1 in infectious and autoimmune disease. Future
studies may reveal whether the frequent co-existence of MS and inflammatory bowel
disease (26,27), which share some common features (28), may be explained by the
involvement of the NRAMP1 gene in both conditions (24). The increased frequency of
allele 5 of the Z-DNA forming polymorphism detected in patients with primary biliary
cirrhosis (PBC) studied by Graham et al. (25), further supports the view that PBC and MS
may be related by a similar autoimmune process (29). The likelihood that the relatively
high frequency of allele 5 detected in the South African MS cohort is caused by co-
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existence ofPBC, was largely excluded by previous studies performed by Reich et al. (50),
recently extended to our study population.
None of the South African MS patients with NRAMP1 allele 5 were anemic, which
highlights the fact that standard parameters of iron status may not necessarily reflect
abnormalities in iron-related genes (51,52). Expression of iron-related genes is furthermore
modulated by environmental (e.g. diet, the menstrual cycle, multiple pregnancies, regular
blood donation) and genetic factors (53), as demonstrated by frequent detection of
clinically unaffected subjects with the Hlf genotype, even in the elderly population (54). It
is well known that a significant inflammatory process can cause interference of iron
delivery for heme synthesis resulting in altered iron levels, such as raised ferritin levels and
decreased transferrin saturation. Two index cases with a family history of MS and their
two female relatives diagnosed with definite MS reported porphyria-like symptoms similar
to those described by Rooney et al. (19), supporting the hypothesis that a disturbance of the
heme biosynthesis pathway may be involved in the etiology of MS in a subgroup of
patients. The likelihood that the allelic association described here may only be due to the
atypical porphyria-like symptoms and is unrelated to MS per se, was largely excluded by
the fact that only two of the five remaining allele 5-positive index cases without a family
history ofMS reported similar symptoms.
The data presented in this study are consistent with pathogenic roles for iron-related
gene-environment interactions in MS and the previous speculation (22) that certain
detrimental NRAMP1 alleles related to autoimmune disease susceptibility, may be
associated with improved survival. Although it remains to be determined whether the
disease phenotype in patients with NRAMP 1 allele 5 is directly related to dysregulation of
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iron or modified susceptibility to viral infections and/or autoimmunity, a combination of
these processes most likely underlie the disease phenotype in a subgroup of South African
MS patients with the potential disease-predisposing promoter variant. In view of the
emerging role of polymorphisms in complex diseases (55), the functional significance of
the Z-DNA forming NRAMPI dinucleotide repeat in autoimmune and infectious disease
susceptibility linked to iron regulation, and minimizing of possible confounding factors in
this association study, we conclude that allelic variation in the NRAMPI promoter may
contribute significantly to MS susceptibility in the South African population of European
descent. A prominent role of iron in the etiology of many neurological diseases may be
forthcoming via its role as a co-factor of hemeproteins which, when dysfunctional, may
give rise to deficiencies in energy production, axonal degeneration and porphyric
neuropathy (56-58).
Stellenbosch University http://scholar.sun.ac.za
94
ACKNOWLEDGEMENTS
The University of Stellenbosch and the Harry and Doris Crossley Foundation supported the
study financially. The South African National Multiple Sclerosis Society is acknowledged
for distribution of patient questionnaires, collaborating neurologists for clinical data of MS
patients and the study participants for their co-operation. Dr. R. Hillermann, Prof. L.
Warnich, Dr. A. Olckers, Dr. L. van Niekerk, Dr. S.l van Rensburg, Prof. W.lH.
Vermaak, Dr. C. Lombard and H. Cloete are thanked for support and helpful discussions.
Prof. H. Schuster, Germany, and Dr. Scott Baden, Scotland, are thanked for control DNA
samples. P. Opperman and L. Breytenbach are thanked for sample collection. IN.P. de
Villiers received student bursaries from the Freda and David Becker Trust and the
Poliomyelitis Research Foundation. This work forms part of a thesis to be submitted in
fulfillment of the requirements for the degree of Doctor of Philosophy, University of
Stellenbosch. The first two authors contributed equally to the study.
Stellenbosch University http://scholar.sun.ac.za
95
REFERENCES
1. Ebers, G.C., and Dyment, D.A. (1998) Genetics of multiple sclerosis. Semin.
Neurol. 18, 295-299.
2. Noseworthy, JH. (1999) Progress in determining the causes and treatment of
multiple sclerosis. Nature 399 (Suppl), A40-47.
3. Bell, JJ., and Lathrop, M. (1996) Multiple loci for multiple sclerosis. Nature Genet.
13, 377-378.
4. Lucchinetti, C., Bruck, W., Parisi, L, Scheithauer, B., Rodriguez, M., and
Lassmann, H. (2000) Heterogeneity of multiple sclerosis lesions: Implications for
the pathogenesis of demyelination. Ann. Neurol. 47, 707-717.
5. Groenewald, lZ., Liebenberg, 1., Groenewald, I., and Warnich, L. (1998) Linkage
disequilibrium analysis in a recently founded population: Evaluation of the
variegate porphyria founder in South African Afrikaners. Am. J. Hum. Genet. 62,
1254-1258.
6. Dean, G. (1967) Annual incidence, prevalence, and mortality of multiple sclerosis
in white South-African-born and in white immigrants to South Africa. Brit. Med J.
2, 724-730.
7. Dean, G. (1985) A new multiple sclerosis epidemic? S. Afr. Med J. 68,630.
8. Rothwell, P.M. and Charlton, D. (1998) High incidence and prevalence of multiple
sclerosis in south east Scotland: Evidence of a genetic predisposition. J. Neurol.
Neurosury. Psychiatry 64, 730-735.
9. Botha, M.C., and Beighton, P. (1983) Inherited disorders in the Afrikaner
population of southern Africa. Part I. Historical and demographic background,
cardiovascular, neurological, metabolic and intestinal conditions. S. Afr. Med. 1. 64,
609-612.
10. Dean, G. Bhigjee, A.I., Bill, P.L., Fritz, V., Chikanza, I.e., Thomas, lE., Levy,
L.F., and Saffer, D. (1994) Multiple sclerosis in black South Africans and
Zimbabweans. J. Neurol. Neurosurg. Psychiatry 57, 1064-1069.
Il. Feder, IN., Gnirke, A., Thomas, W., et al. (1996) A novel MHC class I-like gene is
mutated in patients with hereditary haemochromatosis. Nature Genet. 13,399-408.
12. De Villiers, IN.P., Hillermann, R., Loubser, L., and Kotze, M.l (1999) Spectrum
of mutations in the lIFE gene implicated in haemochromatosis and porphyria. Hum.
Mol. Genet. 8,1517-1522.
Stellenbosch University http://scholar.sun.ac.za
96
13. Valberg, L.S., Flanagan, P.R, Kertesz, A, and Ebers, G.C. (1989) Abnormalities in
iron metabolism inmultiple sclerosis. Can. J. Neurol. Sci. 16, 184-186.
14. Kotze, M.J., de Villiers, J.N.P., Carr, J., Schmidt, S., Warnich, L., and Hillermann,
R (1999) Lack of clinical expression of mutation C282Y implicated in
haemochromatosis and porphyria in two sisters diagnosed with multiple sclerosis.
Eur. J. Hum. Genet. 7 (Suppl), 59.
15. Schiffer, RB., Wetkamp, L.R, Ford, C., and Hall, W.J. (1994) A genetic marker
and family history study of the upstate New York multiple sclerosis cluster.
Neurology 44,329-333.
16. LeVine, S.M., Lynch, S.G., Ou, C.N., Wuiser, M.J., Tam, E., and Boo, N. (1999)
Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple
sclerosis patients. Brain Res. 821, 511-515.
17. Weller, M., List, u., Schabet, M., Melrns, A, and Dichgans, J. (1999) Elevated
CSF lactoferrin in superficial siderosis of the central nervous system. J. Neural.
246, 943-945.
18. Hulet, S.W., Powers, S., and Connor, J.R (1999) Distribution of transferrin and
ferritin binding in normal and multiple sclerosis human brains. J. Neurol. Sci. 165,
48-55.
19. Rooney, RN., Kotze, M.J., de Villiers, J.N.P., Hillermann, R, and Cohen, J.A
(1999) Multiple sclerosis, porphyria-like symptoms and a history of iron deficiency
anemia in a family of Scottish descent. Am. J. Med. Genet. 86, 194-196.
20. Zeman, D., Adam, P., Kalistova, H, Sobek, 0., Kelbich, P., Andel, J., and Andel,
M. (2000) Transferrin in patients with multiple sclerosis: a comparison among
various subgroups of multiple sclerosis patients. Acta. Neural. Scand. 101,89-94.
21. Atkinson, P.G.P., and Barton, CH. (1998) Ectopic expression of Nramp1 in
COS-1 cells modulates iron accumulation. FEBS Lett 425,239-242.
22. Searle, S., and Blackwell, J.M. (1998) Evidence for a functional repeat
polymorphism in the promoter of the human NRAMPI gene that correlates with
autoimmune versus infectious disease susceptibility. J. Med. Genet. 36,295-299.
23. Blackwell, J.M., and Searle, S. (1999) Genetic regulation of macrophage activation:
Understanding the function ofNrampl (=Ity/LshlBcg). Immunol. Lett. 65, 73-80.
24. Hofmeister, A, Neibergs, H.L., Pokorny, RM., and Galandiuk, S. (1997) The
natural resistance-associated macrophage protein gene is associated with Crohn's
disease. Surgery 122, 173-178.
Stellenbosch University http://scholar.sun.ac.za
97
25. Graham, AM., Dollinger, M.M., Howie, S.E.M., and Harrison, D.J (2000)
Identification of novel alleles at a polymorphic micro satellite repeat region in the
human NRAMP 1 gene promoter: Analysis of allele frequencies in primary biliary
cirrhosis. J Med Genet. 37, 150-152.
26. Minuk, G.Y., and Lewkonia, RM. (1986) Possible familial association of multiple
sclerosis and inflammatory bowel disease. N Engl. J Med. 314, 586.
27. Agranof, D., and Schon, F. (1995) Are focal white matter lesions in patients with
inflammatory bowel disease linked to multiple sclerosis? Lancet 346, 190-191.
28. Lossos, A, River, Y., Eliakim, A, and Steiner, I. (1995) Neurological aspects of
inflammatory bowel disease. Neurology 45,416-421.
29. Pontecorvo, M.J, Levinson, JD., and Roth, JA (1992) A patient with primary
biliary cirrhosis and multiple sclerosis. Am. J Med 92, 433-436.
30. Bergsteinsdottir, K., Yang, H.T., Pettersson, U, and Holmdahl, R (2000) Evidence
for common autoimmune disease genes controlling onset, severity and chronicity
based on experimental models for multiple sclerosis and rheumatoid arthritis. J
Immunol. 164, 1564-1568.
31. Weber, J, Werre, JM., Julius, n.w., and Marx, JJ (1988) Decreased iron
absorption in patients with active rheumatoid arthritis, with and without Iron
deficiency. Ann. Rheum. Dis. 47,404-409.
32. Nielsen, O.J, Andersen, L.S., Hansen, N.E., and Hansen T.M. (1994) Serum
transferrin receptor levels in anaemic patients with rheumatoid arthritis. Scand. J
Clin. Lab. Invest. 54, 75-82.
33. Cazzola, M., Ponchio L., De Benedetti, F., et al. (1996) Defective iron supply for
erythropoiesis and adequate endogenous erythropoietin production in the anemia
associated with systemic-onset juvenile chronic arthritis. Blood 87, 4824-4830.
34. Poser, e.M., Paty, D.W., Scheinberg, L., et al. (1983) New diagnostic criteria for
multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13,227-231.
35. Thomson, G. (1995) Mapping disease genes: family-based association studies. Am.
J Hum. Genet. 57,487-498.
36. Miller, S.A, Dykes, D.D., and Polesky, H'F. (1988) A simple salting out procedure
for extracting DNA from human nucleated cells. Nucl. Acids Res. 16, 1215.
37. Kotze, M.J, Theart, L., Callis, M., Peeters, AV., Thiart, R, and Langenhoven, E.
(1995) Nonradioactive multiplex PCR screening strategy for the simultaneous
Stellenbosch University http://scholar.sun.ac.za
98
detection of multiple low-density lipoprotein receptor gene mutations. PCR
Methods Appl. 4,352-356.
38. Stat Soft, Inc. (1995). STATISTICA for Windows [Computer program manual].
Tulsa, OK: Stat Soft, Inc., e-mail: info@statsoft.com, WEB: http://www.statsoft.com.
39. Schneider, S., Roessli, D., and Excofier, L. (2000) Arlequin: A sofware for
population genetics data analysis. Ver 2.000. Genetics and Biometry Lab, Dept, of
Anthropology, University of Geneva.
40. Aisen, P. (1994) Iron Metabolism in Health and Disease. In Iron metabolism: An
evolutionary perspective. (Brock, lH., Halliday, lW., Pippard, M.l, and Powell,
L.W. Eds) pp. 1-30. Saunders Co. Ltd. London.
41. Roskams, AlI., and Connor, JR. (1994) Iron, transferrin, and ferritin in the rat
brain during development and aging. J Neurochem. 63, 709-716.
42. Ponka, P., and Lok, C.N. (1999) The transferrin receptor: Role in health and
disease. Int. J Biochem. Cell. BioI. 31, 1111-113 7.
43. Weiss, G., Wachter, H., and Fuchs, D. (1995) Linkage of cell-mediated immunity
to iron metabolism. Immunol. Today 16, 495-500.
44. Blackwell, J .M. (1996) Structure and function of the natural resistance-associated
macrophage protein (NRAMPl), a candidate protein for infectious and autoimmune
disease susceptibility. Mol. Med. Today 2, 205-211.
45. Risch, N., and Merikangas, K. (1996) The future of genetic studies of complex
human diseases. Science 273, 1516-1517.
46. Greenberg, D.A (1992) Linkage disequilibrium of "necessary" disease loci versus
"susceptibility" loci. Am. J Hum. Genet. 52, 135-143.
47. Haines, JL. Terwedow, HA, Burgess, K., et al. (1998) Linkage of the MHC to
familial multiple sclerosis suggests genetic heterogeneity. Hum. Mol. Genet. 7,
1229-1234.
48. Blackwell, L, Freeman, J., and Bradley, D. (1980) Influence of H-2 complex on
acquired resistance to Leishmania donovani infection in mice. Nature 283, 72-74.
49. Jacobson, M., Schwee, D., Ziegler, A, et al. (2000) A point mutation in PTPRC is
associated with the development of multiple sclerosis. Nature Genet. 26,495-499.
50. Reich, B., Ehlers, 1., Will, H, Heesen, C., de Villiers, IN.P., Rooney, R.N., and
Kotze, M.l (1998) Autoantibodies against nucleolar structures correlate
Stellenbosch University http://scholar.sun.ac.za
99
significantly with an unusual association between multiple sclerosis and porphyria
symptoms. J. Neuroimmunol. 90 (Suppl), 77.
51. Sampietro, M., Piperno, A, Lupica, L., et al. (1998) High prevalence of the
His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Hepatology 27, 181-184.
52. Levy, J.E., Jin. 0., Fujiwara, Y, Kuo, F., and Andrews, N.C. (1999) Transferrin
receptor is necessary for development of erythrocytes and the nervous system.
Nature Genet. 21, 396-399.
53. Whitfield, J.B., Cullen, L.M., Jazwinska, E.C., et al. (2000) Effects ofHFE C282Y
and H63D polymorphisms and polygenic background on iron stores in a large
community sample of twins. Am. J. Hum. Genet. 66, 1246-1258.
54. Willis, G., Wimperis, J.Z., Smith, K.C., Fellows, I.W., and Jennings, B.A (2000)
Haemochromatosis gene C282Y homozygotes in an elderly male population.
Lancet 354,221-222.
55. Bennet, S.T. (1995) Susceptibility to human type 1 diabetes at IDDM2 is
determined by tandem repeat variation at the insulin gene minisatellite locus.
Nature Genet. 9,284-292.
56. Meyer, UA, Schuurmans, M.M., and Lindberg, RL.P. (1998) Acute porphyrias:
Pathogenesis of neurological manifestations. Sem. Liver Disease. 18,43-52.
57. Lindberg, RL., Martini, R, Baumgartner, M., et al. (1999) Motor neuropathy in
porphobilinogen deamÏnase-deficient mice imitates the peripheral neuropathy of
human acute porphyria. J. Clin. Invest. 103, 1127-1134.
58. Heales, S.J., Bolanos, J.P., Stewart, V.C., Brookes, P.S., Land, J.M., and Clark, J.B.
(1999) Nitric oxide, mitochondria and neurological disease. Biochim. Biophys.
Acta, 1410,215-228.
Stellenbosch University http://scholar.sun.ac.za
100
Table 1. Biochemical iron status parameters measured in the serum of 53 South African
MS patients classified according to relapsing-remitting, secondary progressive and primary
progressive disease types.
Variable Relapsing-remitting Secondary progressive Primary progressive
(n=34) (n=10) (n=9)
Mean sn Mean sn Mean sn
Age (years) 40.3 10.9 46.4 12.1 47.8 7.1
S-iron (umol/l) 17.0 6.8 17.8 6.8 16.6 6.4
Transferrin (gil) 2.8 0.4 2.9 0.4 2.6 0.4
Transf sat (%) 25.1 10.6 25.4 12.0 25.4 10.0
Ferritin (ug/l) 77.9 63.5 117.0 83.1 17l.8* 135.7
*Relapsing-remitting vs primary progressive MS: P=0.04
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Table 2. Comparison of allelic distribution between South African MS patients (22 males,
82 females) and controls. The controls (1076 alleles) are grouped according to "atfected-
family based control" (AFBAC), general population-matched controls (l18 males, 211
females) and elderly subjects (67 males, 126 females).
Alleles MS Patients Controls
General AFBAC Elderly Total
223 (34%) 11 (34%) 86 (22%) 320
434 (66%) 21 (66%) 297 (77%) 752
1 (0.1%) 0 3 (0.8%t 4
658 32 386 1076
2 41 (20%)
(30%)
3 160 (77%)
(70%)
5 7 (3%)
(0.4%)*
Total 208
NRAMP 1alleles are numbered according to Ref 25.
*MS vs total control group: P<O.OI, 2 d.f, X2=35.2; MS vs general control group: P<O.OI,
2 d.f, X2=30.8; MS (16 patients) vs AFBAC (32 parental alleles): P<O.OI, 2 d.f,
X2=43.79; MS vs elderly control group: P=O.05, 2 d.f, X2=5.7
#General control group vs elderly subjects: P<O.OI, 2 d.f, X2=16.6
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Table 3. Clinical characteristics of South African MS patients with NRAMP1 allele 5.
Index Patients (n=7) Relatives with definite MS (n=2)
Patient numbers 43 58 67 70 73 81 90 Sister of 43 Aunt of81
Gender F F F F M F F F F
Age (years) 48 38 27 35 45 27 29 39 50
Age of onset (years) 38 24 20 32 41 23 15 15 23
Age at diagnosis ( years) 41 30 24 33 42 23 23 25 46
Disease course RR RR RR RR SP RR RR RR SP
Iron parameters*
Hemoglobin (11.5-16.5 g/dl) 13.5 15.0 14.4 12.6 14.0 12.0 13.7 ND 13.6
Serum iron (6-32 umol/l) 11.0 14.2 23.3 21.5 16.3 29.7 16.1 ND 17.1
Transferrin (1.8-3.8 gil) 3.0 2.4 3.0 3.1 2.3 2.5 3.0 ND 2.4
Transferrin saturation (15-50 %) 15 24 31 30.3 28 52.7 21 ND 31
Ferritin (12-119 ug/l) 33.5 88.8 70.2 157.9 329.5 216.6 14.5 51.2 77.3
F, female; M, male; RR, relapsing-remitting; SP, secondary progressive; ND, not determined
*Reference values for males: hemoglobin 12.5-17.5 g/dl, serum iron 7-35 umol/l, transferrin 1.8-3.8 gil, saturation 20-50%, ferritin 29-
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